Reducing Delays in the Dialysis Treatment by Waller, Aida N. et al.
Worcester Polytechnic Institute
Digital WPI
Major Qualifying Projects (All Years) Major Qualifying Projects
April 2015
Reducing Delays in the Dialysis Treatment
Aida N. Waller
Worcester Polytechnic Institute
Danielle Theresa Davis
Worcester Polytechnic Institute
Kelly Anne Winthrop
Worcester Polytechnic Institute
Rachel Helen Pineda
Worcester Polytechnic Institute
Follow this and additional works at: https://digitalcommons.wpi.edu/mqp-all
This Unrestricted is brought to you for free and open access by the Major Qualifying Projects at Digital WPI. It has been accepted for inclusion in
Major Qualifying Projects (All Years) by an authorized administrator of Digital WPI. For more information, please contact digitalwpi@wpi.edu.
Repository Citation
Waller, A. N., Davis, D. T., Winthrop, K. A., & Pineda, R. H. (2015). Reducing Delays in the Dialysis Treatment. Retrieved from
https://digitalcommons.wpi.edu/mqp-all/1196
Project Number: MQF-MQP 3309 
Reducing Delays in the Dialysis Treatment 
A Major Qualifying Project 
 
Submitted to the faculty of 
Worcester Polytechnic Institute 
in partial fulfillment of the requirements for the  
Degree of Bachelor of Science 
in Mechanical Engineering 
 
by 
Danielle Davis  Rachel Pineda   Aïda Waller   Kelly Winthrop 
 
 
 
 
Approved          April 30, 2015 
 
Prof. M. S. Fofana, Advisor 
Mechanical Engineering Department 
 
 
 
 i 
Abstract 
The functions of the kidneys include maintenance of acid-base balance, water 
removal, electrolyte balance, toxin removal, blood pressure control, erythropoietin 
production, and the metabolism of Vitamin D. The kidneys accomplish these vital 
functions by filtering approximately 180 liters of blood plasma each day, but if they fail 
they are no longer able to perform these tasks. In the United States, the two leading causes 
of kidney failure are diabetes and high blood pressure. Hemodialysis is a type of dialysis 
treatment, which is an artificial process that is able to imitate the functions of the kidneys. 
The treatment process encompasses the removal of blood from the patient, pumping it 
through an external filtering system, and returning the cleaned blood to the body. Each 
treatment takes approximately three to four hours and typically a patient can receive 
hemodialysis treatment three to four times per week. During this process, treatment delays 
are common occurrences. Primary sources of delays exist within the tubing system, the 
water treatment system, the dialyzer, and the needle attachment process. The goal of this 
project is to present alternative designs and suggestions that can be used to reduce treatment 
delays in the hemodialysis process. We researched and recommend designs including a 
modified cartridge, which is based on an existing patent, an armband needle-holding fixture 
and incorporating a new implementation of tubing. These designs focus on reducing travel 
time for blood, securing the needle to the patient, increasing the efficiency of the dialyzer, 
and reducing water contamination. The effectiveness of the results outlined in this report 
are determined by comparison to relevant hemodialysis literature, thus making the 
treatment faster, safer, and more comfortable for the patient. 
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CHAPTER 1. PROJECT MOTIVATION 
2. Introduction 
 Chronic kidney disease (CKD) is a worldwide public health issue. It is a common 
condition in which there is progressive loss of renal function over time. CKD is the ninth 
leading cause of death in the United States, with diabetes and high blood pressure being 
responsible for the majority of cases; they account for 38.4 and 25% of CKD diagnoses, 
respectively. Many people with CKD may be unaware of their illness because the 
symptoms of worsening kidney function are general and can easily be mistaken for other 
things. For this reason, routine screenings are performed on people that are considered to 
be at a high risk for kidney failure, such as those who already have diabetes or high blood 
pressure, or the elderly. Once the kidneys are unable to function and no longer remove 
waste and excess fluids from the body, either a kidney transplant or dialysis is necessary 
to sustain life. 
        Many applicants for kidney transplants are placed on a long waiting list due to the 
shortage of donated kidneys. Therefore, hemodialysis is a common option for patients with 
severe chronic kidney disease. Hemodialysis allows a patient’s blood to be pumped through 
a dialysis machine by connection through a surgically created access point, commonly 
located on the arm. In the machine, the blood is mixed with a dialysate mixture specific to 
each patient, which cleans the blood before it is pumped back into the patient. While 
dialysis effectively allows a person with CKD to extend the length of their life, it is also an 
uncomfortable and time-consuming process that can lead to that person’s loss of 
independence. The primary goals of this project were to identify and reduce sources of 
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delays that take place during dialysis treatment, to improve upon safety wherever possible, 
and to increase patient comfort. To accomplish these goals, the team completed three 
objectives. First, research was conducted to gain knowledge about dialysis delays. Second, 
designs were established to reduce the treatment delays. Lastly, the team analyzed the 
effectiveness of the components in terms of treatment delays. 
The remainder of this report consists of chapters that highlight these essential 
components of the project. Chapter 2 provides an overview of the role of kidneys in the 
human body and describes what happens when they fail. Additionally, the dialysis process 
is explained and new options are explored. Chapter 3 presents the alternative designs and 
recommendations for reducing treatment delays in hemodialysis. These designs include a 
modified cartridge, which houses the extracorporeal circuit of the dialysis process, a 
needle-holding fixture, and a means to simplify the tubing system. The effectiveness of the 
results outlined in this report are determined by comparison to relevant hemodialysis 
literature and clinical studies. Chapter 4 concludes the report, discussing the project 
objectives, constraints, and recommendations for further improvement. 
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CHAPTER 2. KIDNEY DIALYSIS 
2. Introduction 
 The definition of dialysis includes any separation of substances in solution by 
means of their unequal diffusion through semipermeable membranes. In a medical sense, 
however, dialysis refers specifically to the removal of wastes or toxins from the blood 
through these methods. Since the kidneys perform just such functions, medical dialysis can 
be used when kidneys are unable to perform for whatever reason. Naturally, to understand 
dialysis, one must first gain an understanding of kidney operation. This section will explore 
the fascinating workings of the kidneys and various courses of action to take if they should 
fail.  
2.1 The Human Kidneys 
 The human kidneys are two bean-shaped organs, weighing approximately 5 ounces 
each. They are 11cm in length, 5cm wide, and 3cm thick. They are located in the dorsal 
abdominal cavity in the retroperitoneal space and are the most sophisticated filters known 
to man. The kidneys are kept in place by a renal capsule and are protected by layers of fat. 
The kidneys receive between 1000 to 1200 mL of blood every minute (Azar, 2013). Each 
day, they filter through a total of approximately 180 liters of blood. This filtration process 
is complex and specific to the human body, making it a very difficult task to completely 
replicate. 
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2.1.1 Healthy Kidneys 
When kidneys are healthy and functioning properly, they perform a number of very 
crucial tasks for the human body. They maintain the balance of acids and bases, remove 
excess water and toxins, balance the level of electrolytes, control blood pressure, produce 
erythropoietin, and metabolize Vitamin D. Below, in Figure 1, is a diagram breaking down 
the parts of the nephron and the paths in which the blood travels through.  
 
 
Figure 1: Parts of the Nephron 
 
Figure 1 shows where blood enters and exits the kidney, and where urine exits. The 
blood goes into the kidney through the renal artery and then separates into the anterior and 
posterior branches, which return blood via the renal vein. The nephron of an operational 
kidney is what the filtrate flows through each day, which is also called glomerular filtration. 
Nephrons are approximately one million microscopic units and produce urine. The 
production of urine is crucial because it rids the body of excess fluids, electrolytes, and 
wastes.  
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The diagram in Figure 2 shows a more detailed diagram of the structure of a healthy 
kidney. It shows a cross-section, which highlights the major components of a kidney. 
 
Figure 2: The Human Kidney 
The kidney contains renal arteries and veins, which draw in and drain blood to and from 
the kidney, respectively. The figure also shows the kidney medulla, the innermost portion 
of the kidney that holds the nephrons.  
2.1.2 Modes of Failure in the Kidneys 
Renal failure, also known as kidney failure, is when there is a reduction in the 
normal kidney function (i.e. removing wastes from body and excess water). The two 
leading causes of kidney failure mentioned previously, diabetes and high blood pressure, 
can impact any demographic. According to the National Kidney and Urologic Diseases 
Information Clearinghouse (NKUDIC), chronic kidney failure is increasing at the fastest 
rate in senior citizens. The incidence of recognized CKD in people aged 20–64 is less than 
0.5%. 
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Once both kidneys begin to fail, all of the crucial functions of a kidney begin to 
slow down and eventually halt altogether. When the production of urine decreases, there is 
a buildup of fluid throughout the body that can cause various ailments such as hypertension 
(abnormally high blood pressure), edema (excess fluid in body cavities and tissues), and 
dyspnea (difficulty breathing). This decrease in urine production also leads to a dangerous 
increase in electrolyte levels. One electrolyte in particular, potassium, can lead to deadly 
changes in the rhythm of the heart. High phosphorous (another electrolyte) levels lead to 
bone disease and calcification of blood vessels. There is an enormous amount of possible 
conditions, diseases, and ailments that stem from having unhealthy kidneys. For this 
reason, it is imperative to be able to recognize when kidneys are headed toward failure, to 
properly classify kidney disease, and to make sure that a person suffering from this disease 
receives the proper treatment.  
There are two types of renal failure: acute and chronic. As the names suggest, 
chronic kidney failure occurs gradually over a long period of time, whereas acute kidney 
failure happens very rapidly over the course of days or even hours. It is less likely that 
kidneys will fail quickly so CKD is more common. Chronic kidney disease usually takes 
years to progress, which can allow for intervention in the form of lifestyle changes and 
medicine. If it is caught early enough, the progress of CKD can be delayed greatly. Chronic 
kidney disease is broken down into five major stages, which are classified by the 
glomerular filtration rate, or GFR. GFR is a measure of how well kidneys are working and 
can be calculated by a doctor with an equation incorporating blood creatinine test results 
along with factors such as a patient’s age, ethnicity, gender, height, and weight. The higher 
the GFR, the more efficiently the kidneys are functioning.  
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A person with a glomerular filtration rate of 90 or more is classified as stage one 
CKD which is normal kidney function but may have signs indicating potential kidney 
disease. A GFR of 60-89 indicates stage two CKD, which is mildly reduced kidney 
function. A glomerular filtration rate of 30-59 is stage three CKD. A GFR falling between 
15 and 29 is stage four, while a GFR of less than 15 is classified as stage five CKD, also 
known as end stage renal disease, or ESRD. At this final stage of CKD, the kidneys have 
almost lost all ability to do their job. It is at this point in the CKD progression that treatment 
or a kidney transplant is absolutely necessary in order to live (Renal Association, 2013). 
Patients with chronic renal failure cannot be helped unless treatment is started 
promptly. Possible causes of chronic renal failure are diabetes, uncontrolled hypertension, 
polycystic kidney disease, and other genetic illnesses. In some cases of kidney failure, 
people don’t realize their kidneys aren’t functioning properly because of the adaptability 
of kidneys. This is why it is possible to live with only one functioning kidney. The 
surviving kidney would increase its activity to make up for the failed one. In most cases, 
patients will not notice any symptoms in early stages of kidney disease. It is once the 
kidney’s function drops to less than 10% that the body begins to retain toxic wastes and 
extra fluids, leading to swelling and high blood pressure. Due to the other effects that this 
retention of fluids causes such as difficulty breathing, anemia, and weak bones, many 
people also develop cardiovascular disease (DaVita, 2015). 
2.1.3 Kidney Treatment Options 
A person cannot live without at least one functioning kidney. Therefore, once both 
kidneys have begun to fail, a patient must immediately seek medical attention. The 
preferred solution is a kidney transplant, however it is very difficult to qualify for one, and 
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the surgery is risky (About Kidney Transplantation, 2015). If a person is unable to get a 
kidney transplant, other treatment options must be sought. Dialysis is an artificial process 
that keeps your body in balance when your kidneys can no longer function properly. The 
treatment acts to mimic the work done by kidneys in filtering blood, removing water and 
waste products, maintaining a safe level of chemicals in your blood, and controlling your 
blood pressure. While this process has been advanced greatly over time and serves to 
provide a proverbial lifeline for many people, dialysis cannot completely replace a healthy 
kidney. Medicines are required in addition to the treatment to replace the endocrine 
functions. Dialysis alone will not act as a fully functioning kidney; however, it is extremely 
helpful in reducing effects and improving the patient’s quality of life.Dialysis treatment 
can be administered anywhere from a few times per week to several times daily. 
Traditionally, a patient can expect to visit a clinic three to four times per week for three to 
five hours per session. The more frequently sessions are held, the shorter each session 
needs to be. With more improvements to dialysis machines, making them smaller and more 
user-friendly, it is now even possible for dialysis to be performed at home. Aside from the 
possible necessity of special wiring or plumbing, the only requirements for at home dialysis 
are to have enough space, supplies, and a water purification machine. Most people who do 
home dialysis have a helper or nurse who train them ahead of time at a clinic.  
Dialysis is not performed exclusively for people with chronic kidney disease; it can 
be used whenever something needs to be filtered out of the blood. Short-term or urgent 
dialysis, as the name suggests, is performed under more urgent settings. The 
aforementioned acute kidney failure is one such instance. This type of sudden kidney 
failure can be caused by a number of things including but not limited to: direct physical 
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damage to the kidneys, cholesterol deposits, glomerulonephritis, infection, lupus, certain 
medications, drug and alcohol abuse, heavy metal, certain cancers, nerve damage, or blood 
clots located in and around the kidneys (Acute Kidney Failure, 2012). These are all 
instances when wastes and toxins would need to be removed from the body, and would 
cause kidneys to lose their filtering ability rapidly over the course of a few days or even 
hours. In the case of a drug overdose, dialysis can be used to filter out the drugs that are 
present in the blood. In some cases, dialysis can be required as a result of kidney failure 
due to the long-term effects that drug abuse and overdose have on a person’s organs. If 
treatment post overdose is not started immediately, death is the most likely result. Acute 
kidney injury can be fatal, but may also be reversible if treated properly and quickly. With 
this type of kidney injury, dialysis is continued only until blood test results indicate that 
adequate kidney function has been restored, as opposed to ESRF, which requires indefinite 
treatment. There are many different types and forms of dialysis, which will be explained at 
length in the subsequent sections, but each provides aid when the kidneys are unable to do 
their jobs (Acute Kidney Failure, 2012). 
2.2 Types of Dialysis Treatments 
 There are two main types of dialysis: continuous ambulatory peritoneal dialysis 
(CAPD) and hemodialysis. Peritoneal dialysis uses the thin lining of a patient’s abdomen 
called the peritoneum as the filter through which blood passes to be cleansed. Hemodialysis 
is more prevalent and uses an external filter instead of the peritoneum. Overall the dialysis 
process consists of extracting blood from the patient, filtering it to rid toxins, and returning 
the cleaned blood to the body (DaVita, 2015). Hemodialysis can be performed with one or 
two needles. All of these types of dialysis will be discussed in this section. However, in 
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keeping with the scope of the research project, hemodialysis will be inspected in greater 
detail. 
2.2.1 Overview of Peritoneal Dialysis 
Once a doctor has determined that a person needs dialysis treatment, it must be 
decided which type is most appropriate. Peritoneal dialysis may be chosen because there 
are no needles required during each session. At other times, peritoneal dialysis may be 
suggested because there is more dietary freedom with this form. This process can be done 
at home, at work, or on the go. The process of peritoneal dialysis and the connection to the 
patient is shown in Figure 3. 
 
Figure 3: The Peritoneal Dialysis Process 
The peritoneal dialysis membrane was first described by the ancient Egyptians, but 
not well enough to be applied to human medical services (Friedman, 2010). Then in 1923, 
a man named Georg Ganter of the University of Wurzburg in Germany experimented by 
preparing a solution and injecting it into the abdomen of a patient who was suffering from 
obstructive uropathy. The patient suffered from urine not being able to drain through the 
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ureter, which caused swelling of the kidneys. Through the injection of the solution, the 
patient was temporarily relieved but eventually passed away (Wilkie, 2015). This early 
account of peritoneal dialysis lead to more medical advances and improvements up until 
this point. Figure 4 shows an example of a modern peritoneal dialysis machine.   
 
Figure 4: Modern Peritoneal Dialysis Machine 
In 1975, two men named Popovich and Moncrief began to develop CAPD. They 
studied nine patients over a 136-week time period and realized that the kidney infection 
was reduced through continuous treatment (Friedman, 2010). Having a steady flow and 
deposit of fluids in the peritoneal cavity allowed for a removal of wastes and toxins rather 
than receiving intermittent treatments (Friedman, 2010). Following the development of 
CAPD, the compact cycler machine was acquired and another form of peritoneal dialysis 
was established called continuous cyclic peritoneal dialysis or CCPD. CCPD differs from 
CAPD in that it can be done overnight so that the patient doesn’t have to worry about taking 
time out of their day to go get treatment.  
There are guidelines made by the National Kidney Foundation: Dialysis Outcome 
Quality Initiative for receiving CCPD or CAPD treatment. One of the main disadvantages 
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to using peritoneal dialysis is peritonitis, which is a bacterial or fungal infection of the 
abdomen lining. Peritoneal dialysis can also lead to protein loss from blood into the 
dialysate fluid, gastrointestinal complications, and electrolyte imbalances. Aside from 
increased renal function, the advantages of using peritoneal dialysis include lower costs, 
more efficient blood pressure, and anemia control. Compared to hemodialysis, peritoneal 
dialysis works better toward preserving residual renal function. The reasons for this are 
unknown, but some theories are that CAPD has less exposure to non-biocompatible and 
pro-inflammatory tissue, as well as fewer changes in volume, electrolytes, and blood 
pressure compared to hemodialysis (Friedman, 2010). 
2.2.2 Overview of Hemodialysis 
Dialysis was first termed in 1861 by a man named Thomas Graham who was 
working at Anderson’s University in Scotland (Friedman, 2010). He experimented with 
vegetables and noticed that a vegetable parchment coated with albumin operated like a 
semipermeable membrane and allowed crystalloids to diffuse through that coating 
(Friedman, 2010). Later on in 1913, three men, Abel, Rowntree, and Turner, developed the 
first artificial kidney. The first hemodialysis machine was then used on humans in 1943, 
consisting of 30-40m of cellophane tubing wrapped around a drum, which was submerged 
in a tank of dialysate. The advancements lead to hemodialysis being used as a long-term 
treatment for chronic renal failure (Friedman, 2010). Hemodialysis differs from peritoneal 
dialysis in that there is much more preparation for the treatment, the vascular access points 
are different, and the location of treatments is more specific. It incorporates the flow of the 
patient’s blood through an external filter that removes wastes, toxins, and extra fluids. The 
clean blood then travels through a dialysis machine and is returned to the patient via a 
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needle. Figure 5 shows how the patient’s blood is retrieved through an arterial access point 
and travels through tubing within the machine.  
 
Figure 5: Schematic of the Hemodialysis Process 
The dialyzer is the part of the process that performs the actual filtration of the blood. 
It plays a crucial role in the separation of blood and toxins by diffusion and convection and 
will be discussed at length in upcoming sections. Sensors are in place to detect problems 
during the process and immediately stop the machine so that the patient can receive medical 
attention from a nurse or doctor. Many case studies have been done to compare peritoneal 
dialysis to hemodialysis. One example is a case study done by Melissa Stanley, a nurse 
practitioner in the nephrology department of St. Vincent’s Hospital in Melbourne, 
Australia. Her research analyzed patient mortality and modality, in hemodialysis versus 
peritoneal dialysis. She developed a guide for new dialysis patients on what modality to 
choose initially. The process that she followed was a randomized controlled trial that she 
performed on several centers in the Netherlands. The outcomes for several of the centers 
are displayed in Table 1. The volunteers’ dialysis treatment was observed, along with their 
progress and whether they were receiving peritoneal dialysis or hemodialysis. Her results 
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showed that starting early treatment with peritoneal dialysis was more favorable for a 
patient’s improvement compared to starting with hemodialysis. Stanley also found that 
when the results were altered for modality changes, the peritoneal dialysis survival benefit 
was not as evident. Essentially, what she found was that patients who were over the age of 
65 and were receiving treatment because of diabetes had a better survival rate by using 
peritoneal dialysis. Yet when those demographics were removed, peritoneal dialysis was 
not always the best option for patients (Stanley, 2009).  
Table 1: Outcomes from Mellissa Stanley’s Study 
Study ID Study design No. of 
subjects 
Outcome 
Korevaar  
et al. 2003 
RCT 38 Modality, mortality 
 After 5 years of follow up, significant longer-term survival 
favoring PD 
 Adjusted for age, comorbidity & primary kidney disease 
Termorshuizen 
et al. 2003 
Multicentre 
prospective, 
observational 
cohort of 
incident 
patients 
1222 Modality, mortality 
 Follow up until Tx or death (or 5 years) 
 No statistical differences in mortality in first 2 years, then 
PD>HD. 
Subgroup analysis: 
 Patients <60 w/ DM had increased RR on HD than PD in 
first 2years 
 RR for patients >60 higher on PD after 2 years (irrespective 
of DM status) 
Liem  
et al. 2007 
Dutch End 
Stage Renal 
Disease 
Registry 
16,600 from 
47 centres 
Modality, mortality 
 Not able to adjust for comorbidity 
 Initial survival advantage for PD. Over time, w/ advancing 
age & in the presence of DM (as PRD) this survival reverses 
Vonesh  
et al. 1999 
US registry 
data of incident 
& prevalent 
patients 
203,958 Modality, mortality 
 Not adjusted to comorbidity 
 RR (PD vs. HD) 1.28-DM>50 years (sig.) 0.89-DM <50 
year (sig.) 
 Females & patients >50 years-significantly lower risk of 
death if on PD 
Stack  
et al. 2003 
USRDS 
Historical 
prospective 
cohort of 
incident 
patients 
107,922 Modality, mortality 
 2 years of follow up 
 Significantly higher mortality risk w/ patients on PD & CHF 
(DM & non-DM). 
 Survival advantage if non-DM & non-CHF on PD at least in 
the first 6 mo. 
Ganesh  
et al. 2001 
USRDS 
historical 
prospective 
cohort of 
incident 
patients 
107,922 Modality, mortality w/ or w/out cad 
 2 years of follow up 
 Underreporting of comorbidities w/ registry data 
 Survival benefit in first 6 mo. T PD, lose this at 12 mo. 
 DM w/ CAD significantly higher mortality on PD 
 Patients w/o CAD 9% lower mortality on PD 
 Caution exercised in recommending PD as initial choice in 
those w/ proven CAD whereas either modality 
recommended if no CAD 
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 From these studies, it can be concluded that peritoneal dialysis has an equal or 
improved survival rate for younger patients without diabetes (Stanley, 2009). Additionally, 
peritoneal dialysis has an equal or lower mortality rate for the first two years of treatment 
(Stanley, 2009). Finally, for patients over the age of 45 with diabetes, the best form of 
treatment is hemodialysis (Stanley, 2009). With a significant increase in the number of 
people that suffer from end stage renal disease, the demand for hemodialysis treatment has 
increased amongst patients. Hemodialysis totaled in nearly $17 billion in expenditures in 
2006 (Friedman, 2010). This industry has expanded so much that hemodialysis has become 
a major part of most patients’ lives. 
2.2.3 Single Needle Dialysis Treatment 
 Traditionally, hemodialysis is performed with two needles: one taking the blood 
from the patient prior to cleaning and a second needle used to return the blood afterward. 
This standard type of hemodialysis can be referred to as double needle dialysis. There is a 
less common way to perform hemodialysis called single needle dialysis (SND). With this 
method, a single device accesses the patient’s blood. Obviously, the needle in use cannot 
be extracting and returning blood simultaneously. Thus, an alternating-flow schedule is 
required. During the arterial phase, blood is taken from the patient over a time interval 
denoted tA. The volume of blood extracted (VS, or stroke volume) over this time must be 
stored within the extracorporeal system. During the venous phase, the cleaned blood is 
taken from the holding chamber and returned to the patient over a time interval denoted tv 
(Matthias, 2008).  
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 There are two main setups for single needle dialysis, which are each shown in 
Figure 6. In both setups, the arterial and venous lines are connected to the cannula using a 
Y-shaped tube.  
 
Figure 6: Two Setups of Single Needle Dialysis 
In the first setup (Figure 6-A), the arterial line leads to the blood pump and dialyzer, 
denoted D. At the beginning of the arterial phase, clamp Cla is opened, clamp Clv is closed, 
the blood pump is started, and the dialyzed blood is pumped into the holding chamber (Co). 
As the volume of blood being stored in the chamber increases, the remaining air becomes 
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compressed. Once the pressure reaches a preset maximum, the blood pump stops and the 
venous phase begins. Clamp Cla closes as Clv opens. The compressed air in the chamber 
then forces the blood in chamber Co into the venous line and back into the patient. Once 
the pressure reaches a minimum, the arterial phase starts again (Matthias, 2008).The second 
setup (Figure 6-B) is used more often. This method uses two blood pumps, a venous one 
(BPv) and an arterial one (Bpa). The venous pump is paused and clamp Clv is closed as 
the chamber is filled during the arterial phase. During the venous phase, the arterial pump 
is paused and the clamp is opened. At a maximum pressure, the venous pump empties the 
chamber and the blood goes through the dialyzer back to the patient. Once the chamber 
reaches its lower limit, the arterial cycle begins again (Matthias, 2008). 
 The chamber pressure limits that trigger the start of the venous and arterial cycles 
are higher in the setup in Figure 6-A than those in Figure 6-B. A typical pressure range for 
the first setup could be 100–300 mmHg whereas in the second setup, the pressure range is 
80–180 mmHg. In both setups for single needle dialysis, the flow rate of blood pumped 
during the arterial phase is denoted QA; this is the rate at which the blood is pumped into 
the chamber. The stroke volume, which is pumped in the arterial phase, can be found using 
VS = QA. * tA. Timing and flows during SND are defined by this stroke volume VS , along 
with QA, QV, and the ultrafiltration rate (UFR). The average blood flow rate during SND is 
the blood volume pumped into the dialyzer (stroke volume VS) per cycle time (tC = tA + 
tV). This mean BFR can be expressed as: 
𝑄𝑀 =
𝑉𝑆
𝑡𝐶
=
𝑄𝐴∗(𝑄𝑉+𝑈𝐹𝑅)
𝑄𝐴+𝑄𝑉
                                            (1) 
 Single needle dialysis has the advantage of only having one venipuncture but it 
otherwise has a number of disadvantages. SND is not the preferred method of 
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hemodialysis, but the need for it arose because there are often times when a patient’s body 
simply cannot handle two punctures, such as in the existence of an infection. SND is 
usually less efficient and requires certain modifications in order to be performed. Clearly, 
there is a possibility of needing an additional blood pump, a special arterial line with two 
pump segments, and the compliance chamber. Some dialysis machines have 
accommodations to allow for them to be set up for SND, but some do not, and the extra 
parts can be a hassle (Levy, 2009). Another major shortcoming of single needle dialysis is 
that it poses an increased risk of recirculation. There is expected increased recirculation of 
blood in the extracorporeal circuit during SN treatment, even when using the recommended 
administration sets, dialyzers, catheters, and fistula needles. Recirculation occurs when 
dialyzed blood somehow returns to the dialyzer inlet rather than returning to the systemic 
circulation. This poses a problem in dialysis because it reduces solute concentration 
gradients across the dialysis membrane by mixing dialyzed blood with blood that has not 
been dialyzed. It usually reduces the efficiency of dialysis by lowering the concentration 
of urea and other solutes that are at the dialyzer inlet (Levy, 2009). 
 There are two types of recirculation: cardiopulmonary and access. 
Cardiopulmonary recirculation occurs via an AVF or AVG. Dialyzed blood gets returned 
to the venous circulation and mixes with venous blood that has not been dialyzed yet. This 
mixed blood then becomes the arterial supply that is going to the dialyzer. 
Cardiopulmonary recirculation can be approximated by: 
𝐷𝑖𝑎𝑙𝑦𝑠𝑒𝑟 𝐶𝑙𝑒𝑎𝑟𝑎𝑛𝑐𝑒 (𝐾)
𝐶𝑎𝑟𝑑𝑖𝑎𝑐 𝑂𝑢𝑡𝑝𝑢𝑡−𝐴𝑐𝑐𝑒𝑠𝑠 𝐵𝑙𝑜𝑜𝑑 𝐹𝑙𝑜𝑤
                                    (2) 
Access recirculation occurs when blood that has just been dialyzed returns directly to the 
dialyzer inlet. This is usually due to retrograde (opposite) blood flow within a fistula or 
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graft, but can also be caused by a drop in BFR below 350 mL/min. Access recirculation 
only occurs if access flow rate is less than the dialyzer blood pump flow rate; it can be 
calculated by: 
𝑆−𝐴
𝑆−𝑉
∗ 100                                                       (3) 
where S is a measure of urea in a systemic arterial blood sample, A is a measure of urea in 
an arterial blood sample, and V is a measure of urea in a venous blood sample. Single 
needle dialysis provides a necessary alternative method for hemodialysis, but given the 
aforementioned dangers, it should only be used when needed (Levy, 2009).  
2.3 A Detailed Look into Hemodialysis Treatment 
 Being that hemodialysis is the more common form of dialysis, this is what the 
team decided to focus the project on. It is a thorough process that requires work from 
trained professionals in addition to patient compliance. There are many steps from the 
start of treatment to the end, such as the preparation of an access point or the travel path 
of blood outside of the patient’s body. 
2.3.1 Dialysis Access Points 
 Preparation is a crucial part of hemodialysis treatment and it includes accessing the 
veins and arteries. An access creates a way for blood to be removed from the body, circulate 
through the dialysis machine, and then return to the body at a rate that is higher than can 
be achieved through a normal vein. There are three main types of dialysis access. The first 
is an arteriovenous fistula (AVF), which is the preferred method. An AV fistula is a 
surgically made connection between an artery and a vein (NIH, 2014). These fistulas are 
usually created in the forearm or upper arm, as shown in Figure 7. 
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Figure 7: Arteriovenous Fistula 
This type of access entails much planning because the fistula requires 2 to 3 months to 
mature after it is created (NIH, 2014). The advantages to using the AV fistula are that there 
is less of a chance to develop clots or infections.  
 The second type of access point for hemodialysis is an arteriovenous graft. Creating 
a graft for the patient is only necessary if their veins are too small to use an AV fistula. An 
arteriovenous graft is made by using a biocompatible plastic tube that is looped and 
connects an artery to a vein, as the AV fistula does. The graft is inserted into the patient 
through an AV graft surgery, just as the fistula is inserted into the patient (NIH, 2014). In 
Figure 8, you can see a schematic of the AV graft in a patient’s forearm.  
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Figure 8: Arteriovenous Graft 
If the AV graft is properly cared for there are typically no problems. Yet compared to the 
AV fistula, the graft is more likely to develop infection or blood clots (NIH, 2014).  
The final type of access point a doctor can use for a patient is the central venous 
catheter. This is a temporary access point for patients that need treatment immediately and 
before permanent access can be surgically inserted and matured. The catheter is positioned 
in an internal vein located around the neck, chest, or upper leg area. This catheter that is 
used allows for two-way flow of blood and therefore, has two tubes with caps that are 
designed for the two-way blood flow. There are clamps to control the flow of the blood 
either from the patient to the machine or from the machine back to the patient, which are 
shown in Figure 9. Again, unlike the AV fistula, the catheter has a high probability of 
developing infection and blood clotting, which is very dangerous for the patient.  
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Figure 9: Central Venous Catheter 
Once a form of access is established, a nurse can gain access to the patient’s blood through 
cannulation. Cannulation is a process in which a cannula, or tube, is placed inside a vein 
through use of a needle to provide venous access. This process can be broken down into 
steps that should be taken prior to, during, and after cannulation. In order to properly 
cannulate a dialysis access, one must identify the type of access and direction of blood 
flow, select the needle site, prepare the skin, administer local Anesthesia if necessary, select 
needle, follow cannulation technique, secure the needle, address and solve potential 
problems, remove the needle, and finally, discharge the patient (Brouwer, 2011). There are 
a number of decisions to be made throughout this procedure, most of which are medical 
tasks that would be commonplace to trained healthcare professionals. There are, however, 
many factors pertaining to cannulation that may contribute to delays in the dialysis process. 
Step two in the procedure is selection of the needle site. The venous needle must 
always point towards the venous return, while the arterial needle can point in either 
direction. On a graft, if certain complications such as infections occur and make it so that 
only one side is usable, the needles may both be on the same side, but must point in opposite 
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directions, as shown in Figure 10. In these cases, the needles must be at least one inch apart, 
hub-to-hub.  
 
Figure 10: Two Needles Within an AV Graft 
These needle sites that are chosen for cannulation must be regularly rotated to extend the 
lifespan of the access and to prevent the formulation of a pseudoaneurysm, which is a solid 
swelling of clotted blood within the tissues. Step five in the procedure leading to 
cannulation is the all-important selection of the needle. Figure 11 shows the various parts 
of a standard surgical needle. 
 
Figure 11: The Parts of a Standard Needle 
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The type of needle used during dialysis is a fistula needle, shown in Figure 12, which has 
rubber or plastic wings for a better grip and ease of adhesion to the patient’s body. They 
are also usually equipped with a color-coded clamp, which differentiates an arterial needle 
from a venous needle. In terms of materials, there is no variation between fistula needles 
and typical surgical needles, which are made of high quality stainless steel. 
 
Figure 12: Fistula Needle 
The gauge of the needles used should be ordered by the nephrologist to ensure that the 
proper blood flow rate (BFR) is achieved. Needles are organized by gauge, ranging from 
7-34, each with different inner and outer diameters. The fistula needle, however, generally 
only encompasses gauges 14-18. Table 1 shows the inner and outer diameters for the needle 
gauges used during dialysis. 
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Table 2: Standard Surgical Needle Sizes 
Gauge Outer Diameter (mm) Inner Diameter (mm) 
14 2.108 1.600 
15 1.829 1.372 
16 1.651 1.194 
17 1.473 1.067 
18 1.270 0.838 
 
Though the diameters of the gauges are standardized, different companies claim 
slightly different attainable BFRs for the different gauges. However, one thing remains 
constant: The larger the inner diameter is and the shorter the needle length, the higher the 
BFR that can be attained under different pressures (FMC, 2015). An explanation for the 
variation in possible BFRs attainable is that the needle lengths can vary. Gauges 14-18 tend 
to range from 15mm to 25mm in length, but each gauge can come in multiple lengths. 
Figure 13 shows a graph from a German healthcare company called Bionic Medizintechnik 
that shows the correlations between gauge and blood flow rates at different pressures for 
their fistula needles, which are named “Bionic.” 
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Figure 13: Blood Flow Rates in Bionic Brand Needles 
Figure 14 shows a similar graph from another company, Fresenius Medical Care, which is 
the leading network of dialysis facilities across America and the world. As can be seen 
from comparing the two companies, there is very slight variation in flow rate for each gage, 
but both maintain a positive slope. 
 
Figure 14: Blood Flow Rates in Bionic Brand Needles 
Once a doctor chooses the gauge, the length of the needles can be decided and 
altered by the dialysis staff members. The length of the fistula needle from tip to hub ranges 
from about 15mm to 25mm. The needle only needs to be long enough to reach the access. 
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The depth of the access beneath the skin depends upon a number of variables. Veins and 
arteries are located at different depths throughout different areas of the body. The depth 
also depends upon the size of the patient. Larger patients will have more distance to travel 
from the surface of the skin to the veins. In addition to consideration of dimensions, the 
needles chosen for dialysis should always have a “back eye” to attain the optimal flow. 
Figure 15 exemplifies what a back eye looks like. 
 
Figure 15: Back Eye on a Needle 
Step six in the process is the actual cannulation technique. With all of the prep work 
done, the nurse is now ready to insert the needle. The fistula needle must be held by its 
wings, with the bevel facing upward, as illustrated in Figure 16A. For an AV fistula, the 
needle must be held at a 20-35° angle from the skin. For a graft, it must make a 45° angle. 
The nurse will know when the needle is within the wall of the fistula or graft because blood 
flashback should be visible. Blood flashback is the appearance of blood in the hub of a 
catheter. At this point, the needle should be advanced no more than 1/8 of an inch. The 
needle bevel should then be rotated 180°, as shown in Figure 16B. This rotation is to help 
prevent posterior wall infiltration, which can occur if the tip of the needle accidentally 
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punctures the bottom wall of the fistula or graft. After rotation, the needle should be leveled 
out, or flattened against the skin, depicted in Figure 17. Lastly, the needle should be 
advanced cautiously up to the hub. 
 
Figure 16: (A) Insert Needle, Bevel Up, (B) Rotate Needle 180° 
 
Figure 17: Leveling out of Needle with Skin 
Step seven is to secure the needle. There are many effective ways to secure a fistula 
needle and any legitimate technique can be followed. The important aspect is that the 
needle is kept from coming loose during treatment. Once such method is the butterfly tape 
technique. First, a piece of adhesive tape 1” x 6” is placed under the needle wings. Next, 
the tape is folded to cross over the needle site. A bandage is then placed over the needle 
and secured by a second piece of tape. If the needle shifts after it is secured, gauze pads 
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may be placed under the needle to correct the angle. Step eight is less of a procedural step 
and more damage control. There are various things that can go wrong during the 
cannulation process so proper problem solving is crucial. There are some tips that can and 
should be followed in the event of any accidents. If resistance is felt at any time during 
needle advancement or needle position change, the needle should be pulled back and the 
angle should be redirected. 
In the event of infiltration of the back wall of the fistula or graft, the course of action 
depends on the conditions of the situation. If the patient has not yet received heparin, the 
needle should be pulled out and pressure should be applied to the exit site by placing two 
fingers along the access, covering at least a one-inch area. If, however, the patient has 
already received heparin at the time of infiltration, the puncture site must be carefully 
assessed. If the needle site remains stable with no increase in size or swelling, it is safe to 
keep in place for the duration of the dialysis treatment, but ice should be applied over 
infiltration site. If a solid swelling is observed, the needle should be removed and digital 
pressure should be applied. It is important to note that pressure should never be applied 
while the needle is inside the patient. If the needle had to be removed due to infiltration, a 
new needle should be used to perform cannulation and a new spot should be chosen as far 
away from the first as possible. The ninth step is the removal of the needles. First, the tape 
should be carefully and slowly removed once dialysis is complete. The needles should be 
withdrawn slowly, one at a time, at a 20° angle until the entire needle is out of the patient. 
Once out, the patient should use their index and middle fingers to apply mild digital 
pressure to a gauze pad over the needle exit sites, with the thumb wrapped around to the 
other side of the limb. This pressure should be maintained for about 10 to 15 minutes. 
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The final step of the cannulation process is to discharge and dress the patient. An 
adhesive bandage should always be placed over the cannulation sites. Before leaving the 
dialysis unit, the patient should be assessed by their nurse with a stethoscope over the 
access to make sure the rushing-roaring sound can be heard. A strong pulse or buzzing 
sensation should also be felt when fingers are placed over the access. These are signs that 
blood is flowing through the vessel and the fistula or graft is working properly. Once 
cannulation has taken place, the process of dialysis can begin. 
2.3.2 Preparation for Hemodialysis 
 Hemodialysis does not solely include the filtration of blood. There are a number of 
steps that must be taken prior to the treatment process. To begin, a lot of work goes into 
preparing the dialysate. Hemodialysis patients are exposed to contaminants from the water 
that is mixed with the dialysate. This may not seem so crucial at first, but considering that 
dialysis patients are exposed to 25 times more water than a healthy person, the impurities 
and excess minerals can quickly add up (Friedman, 2010). Assuming a patient receives 
treatment 3 times per week, the total amount of water required is between 300 to 600 liters, 
depending on the prescription. Patients who receive dialysis during their sleep are exposed 
to 500 to 860 liters per week (Coulliette, 2013). This means that the water decontamination 
process must be done carefully. Figure 18 shows some tanks required for a dialysis water 
treatment system (“Up to 35 stations,” n.d). 
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Figure 18: Water treatment system for dialysis 
 The main source of water for hemodialysis facilities and home dialysis is usually 
local drinking water supplies (Coulliette, 2013). Although the cities, towns, and other 
suppliers of drinking water are required to follow specific standards, there are still 
significant amounts of contaminants in the water. Therefore, the water is treated, purified, 
and transported through a water distribution system prior to reaching the patient in a 
dialysis center. This water is then used in the preparation of dialysate concentrates and for 
proportioning concentrates to produce the final dialysate bath (Coulliette, 2013). 
Hemodialysis centers’ goal is to achieve the best care by providing high quality and safe 
hemodialysis water and dialysate to the patients. Dialysis water treatment, system design, 
and distribution material choices are all important factors when it comes to achieving that 
standard (Coulliette, 2013). There is no single water system design for dialysis centers 
because it varies based off the quality of the feed water and the local requirements. 
However, an example of a water treatment arrangement that is commonly used is depicted 
in Figure 19.  
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Figure 19: Common Water Treatment Arrangement (Direct Feed Loop) 
 There is a Backflow Preventing Device (BFD) at the start of the system. This is 
where the feed water passes through. A valve is in place to prevent dialysis water from 
flowing back to the water supply (Ahmad, 2005). Once water enters the water treatment 
system, removal of chemical and microbial contaminants begins. These are done through 
two phases: pretreatment and water treatment. Pretreatment is the process through which 
contaminants are removed from feed water to protect the other components that are 
downstream. Pretreatment is followed the water treatment, which is the physical and/or 
chemical removal of the remaining contaminants in the water. 
 The pretreatment segment of the water purification process utilizes the following 
equipment: temperature blending valve, multimedia depth filter, granular activated carbon 
filter, softener, and additional smaller filters (Coulliette, 2013). The temperature blending 
valve blends heated water with cold water and assures a constant temperature. The reverse 
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osmosis (RO) unit works most efficiently if the feed water is at 77 degrees Fahrenheit. 
Filters are placed on the water line with increasingly smaller pores to remove large 
contaminants. The first filter is used to remove large matter such as silica and clay particles 
from the feed water. Activated carbon filters are either a tank or column in which granules 
of activated carbon are packed in a cartridge. Water flows around those granules and 
organic matter, chlorine, and chloramine are absorbed by the carbon. Unfortunately, 
activated carbon filters are not very effective filters and cannot be used alone because they 
release abrasive particles. Therefore, it is recommended that micro filters are inserted after 
the carbon tank to remove the particles. Additionally, two other challenges are present 
when the activated carbon filter is in use. These complications are exhaustion of the carbon 
and microbial growth. One can take action to prevent exhaustion of the carbon by 
monitoring the post-carbon water and changing the filter when needed. Microbial growth 
can be controlled by periodically monitoring the carbon filter and flushing with chlorine 
(Ahmad, 2005). 
 Monitoring of the activated carbon filter is very important. Chlorine and chloramine 
removal is one of the most important functions of the filter because chlorine and 
chloramines are high level oxidative chemicals. They kill bacteria in municipal water 
systems but destroy red blood cells if not filtered out prior to dialysis. It is necessary to 
remove these chemicals prior to RO because the RO unit is not capable of removing the 
chemicals and the chemicals have been known to destroy the RO membrane (Monitoring, 
2005). Post carbon water should be monitored for chlorine and chloramine levels that 
exceed the acceptable range. If levels go beyond the acceptable range, the carbon filter 
needs to be changed.  
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 Water softeners protect water treatment devices such as RO and deionizer (DI) by 
removing large concentrations of cations from the water. The water contains high 
concentrations of calcium and magnesium, these minerals make the water hard and in 
return limit the life of treatment devices. Water softeners use resin beads fixed with sodium. 
Water passes through the beads where there is an exchange of calcium, magnesium, iron, 
and manganese with sodium, producing a softer water hardness (Ahmad, 2005). Figure 20 
shows a schematic of the ion exchange process. 
 
Figure 20: Ion exchange process in a water softener 
 Water treatment follows the pretreatment process and consists of the following 
components: reverse osmosis (RO), deionization (DI), storage tank, and ultraviolet 
irradiator (UV) (Coulliette, 2013). Reverse osmosis is a cost effective method for water 
purification that removes organic and inorganic solutes by filtration through a tight 
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membrane. The filtered water from RO is called “permeate” or “RO water”, while the 
unfiltered water that contains the rejected solutes and substances is called “rejection” or 
“brine”. The osmolarity of the brine is stronger than the osmolarity of permeate. Therefore, 
the water would normally move in the direction of the filtered water to the brine because 
of the high osmotic pressure. However, with RO, a mechanical force is applied with a pump 
to the brine in order to push it across the membrane and filter the water. Shown in Figure 
21 is a schematic diagram showing regular osmosis and reverse osmosis. In regular osmosis 
the solution moves from area of low concentration to area of high concentration. In RO, a 
force is applied to go against the concentration gradient.  
 
Figure 21: Regular Osmosis (left) & Reverse Osmosis (right) 
 The membrane for RO is designed by selecting one of the three following materials: 
cellulosic, synthetic, or thin composite. RO also uses either parallel plates, hollow fibers, 
or spiral wounds. Water pH, disinfectants, and bacteria can destroy the RO membrane, 
similarly to chlorine and chloramine. Chemicals are most likely to harm synthetic 
membranes while composites tend to be more resistant to destruction. The membrane’s 
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performance must be measured to make it possible to monitor the removal of solutes. This 
is done by measuring the resistivity of RO water. Pure water is highly resistant to electrical 
current. When ions are present in the water, the electrical conductivity increases. When the 
production to rejection ratio is greater than 0.85, the water is acceptable. When the ratio is 
less than 0.80, the membrane needs to be changed. The production to rejection ratio is 
calculated with formula below: 
𝑟𝑒𝑗𝑒𝑐𝑡𝑖𝑜𝑛 𝑟𝑎𝑡𝑖𝑜: 1 −
𝐶𝑜𝑛𝑑𝑢𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑜𝑓 𝑅𝑂
𝐶𝑜𝑛𝑑𝑢𝑐𝑡𝑖𝑣𝑖𝑡𝑦 of 𝑓𝑒𝑒𝑑 𝑤𝑎𝑡𝑒𝑟
∗ 100                     (4) 
where Deionization (DI) is an ion exchange process using cationic and anionic resins in 
order to remove inorganic ions. The process occurs by cationic resin exchanging dissolved 
cations with H+ ions, and anionic resin exchanging dissolved anions with OH- ions. 
Together, H+ and OH- ions produce pure water without cations and anions. DI is not an 
effective way to remove organic and additional contaminants. It is also a site for bacterial 
growth and can lead to downstream contamination. A continuous electric deionizer is a 
more efficient option. It uses an electric current ion exchange membrane and resins to 
remove the unwanted ions, producing high quality water that contains less bacterial growth 
because the water is in continuous flow. A DI is used in conjunction with an ultraviolet 
(UV) treatment that kills bacteria, followed by an ultra-filter that removes bacterial 
fragments. The efficiency of UV is dependent upon the depth of penetration and the water 
flow rate (Ahmad, 2005). The water treatment process is at a higher risk of bacterial 
infection. Parts downstream from activated carbon filter, which eliminated chlorine 
through its process, resin and porous elements (softeners, resinous deionizers), and filters 
made with activated carbon, storage tanks, and stagnant water are at an increased risk of 
bacterial infection (Perez-Garcia, 2000). 
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 The dialysis water system follows a loop flow design. It is a continuous cycle 
throughout a dialysis facility where the purified water goes to either the RO or to a storage 
tank (Andrysiak and Philip, 2002). There are two categories of distribution systems. They 
are direct feed and indirect feed. The direct feed loop delivers water directly from the RO 
system to the water distribution loop. The product water that is not used for dialysis is sent 
back to the RO system. The direct loop was shown in Figure 19 within the common water 
treatment arrangement. The indirect feed loop holds water in a storage tank after RO. 
Purified water is delivered to a tank where water is pumped to the distribution loop that 
returns water back to the tank daily (Ahmad, 2005). Figure 22 shows an example of a 
schematic of an indirect feed loop. 
 
Figure 22: Common Water Treatment Arrangement (Indirect Feed Loop) 
 38 
 There are general requirements for the system design and selecting the correct loop 
flow velocity. Direct feed systems require a minimum flow velocity of 1.5 feet per sec 
(FPS) at the end of the loop and at all systems operating and drawing water. Indirect feed 
systems require a minimum flow velocity of 3FPS (average of 3-6 FPS). Flow velocity is 
important because velocities that are too high create excess noise and heat, an increase in 
water, and higher costs to operate the pumps. Throughout the system design, flow rates in 
pipes are higher at the beginning of a system and then decrease throughout the pipes. This 
is because the volume of the water decreases as equipment removes components such as 
various contaminants. Decreasing the size of the piping throughout the loop can counteract 
the flow rate differences. This will help the water system remain at a high velocity, helping 
to maintain a constant pressure (Andrysiak and Philip, 2002). 
 Material choice is another important aspect of the water treatment system. There is 
a list of distribution materials and disinfectants that are recommended by the AAMI. Such 
materials are polyvinylchloride (PVC), chlorinated polyvinylchloride (CPVC), 
polyvinylidene fluoride (PVDF), cross-linked polyethylene (PEX), stainless steel (SS), 
polypropylene (PP), polyethylene (PE), acrylonitrile butadiene styrene (ABS), and 
polytetrafluorethylene (PTFE). Such disinfectants are sodium hypochlorite (chlorine 
bleach), peracetic acid, formaldehyde, hot water, and ozone (dissolved in water). Peracetic 
acid is compatible with all materials and is of importance because incompatibility between 
materials and disinfectants can cause leaching and/or corrosion of the materials. PVC and 
SS are the most commonly used distribution materials in hemodialysis. PVC is the most 
common because of its ease of availability and low cost. (Coulliette, 2013). 
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 In a water treatment system, the question of including a storage tank in the design 
is proposed. If there is a tank, it should have a bowl shaped base, tight lid with a 
hydrophobic air filter, and receive the proper maintenance. The tank should be cleaned and 
disinfected weekly. If that is not possible, then it should be done on a biweekly or monthly 
schedule. These considerations are important because the formation of biofilm in the water 
distribution system is significant. From data showing outbreaks, it is demonstrated that 
patients require water and dialysate that is microbiologically as clean as possible. Once 
developed, biofilm is extremely difficult to remove. This is because it is highly resistant to 
disinfectants due to its bacterial structure and formation of exopolysaccharides (EPS). 
Therefore, it is a priority to prevent the initial growth of biofilm by selecting the appropriate 
materials for the distribution system and the proper disinfectants (Coulliette, 2013). 
 All the components in the water treatment system ensure that the water being 
provided to dialysis patients is of the highest quality and reaches the recommended 
standards. Drinking water suppliers follow the United States Environmental Protection 
Agency (EPA) requirements under the Standard Drinking Water Act (SDWA), which 
shows accepted chemical and microbial contaminant levels. A list of contaminants and 
their maximum allowable contamination level (MCL) regulated by the EPA can be found 
in the appendices. These standards are not enough alone to protect the patient. The dialysis 
centers are required to meet the requirements of the Centers for Medicare and Medicaid 
Services (CMS) conditions for coverage, which contains various other requirements in 
addition. The CMS usually adopts the more stringent standards set forth by the Association 
for Advancement of Medical Instrumentation (AAMI) (Coulliette, 2013). The AAMI 
recommends bacteria levels of less than 200 colony-forming unit per milliliter (CFU/ml) 
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with an action level at 50 CFU/ml and endotoxin levels of less than 2.0 endotoxin units per 
milliliter (EU/ml) with an action level at 1 EU/ml. Other countries have even stricter 
standards, as shown by the European recommendations. European Pharmacopoeia suggests 
bacteria levels at 100 CFU/ml and endotoxin levels at 0.25 CFU/ml with an action level of 
25 and 0.0125 EU/ml, respectively (Andrysiak and Philip, 2002). Table 2 compares the 
chemical limits allowed in municipal drinking water with chemical limits allowed in 
dialysis water. The data is from CMS, AAMI, and EPA (Coulliette, 2013). 
Table 3: Chemical Limits for Municipal versus Dialysis Water 
Contaminants Municipal 
Drinking Water 
Dialysis Water 
Toxic Chemicals mg/L mg/L 
Aluminum 0.05–0.2 0.01 
Chloramine 4 0.1 c 
Chlorine 4 0.5 c 
Total chlorine – 0.1 
Copper 1.3 0.1 
Fluoride 4 0.2 
Nitrate (as N) 10 2 
Sulfate – 100 
Zinc – 0.1 
Trace Elements mg/L mg/L 
Antimony 0.006 0.006 
Arsenic 0.01 0.005 
Barium 2 0.1 
Beryllium 0.004 0.0004 
Cadmium 0.005 0.001 
Chromium 0.1 0.014 
Mercury 0.002 0.0002 
Selenium 0.05 0.09 
Silver 0.1 0.005 
Thallium 0.002 0.002 
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 The need for such strict standards is to help reduce the risk of microbial growth and 
chemical exposure that occurs when water is contaminated and not maintained properly. 
When water is contaminated by chemicals, bacteria, and endotoxins, there are many 
potential health risks for a patient. The guidelines are in place to help prevent those 
complications (Coulliette, 2013). Chemical contaminants will cause chemical toxicity and 
adverse health effects for a patient if they are exposed to certain chemicals. Chemical 
toxicity causes speech and motor difficulties, seizures, nausea, hypotension, and diarrhea. 
An example of a contaminant with adverse effects is lead, which would cause a patient 
abdominal pain and muscle weakness. Sulfate would cause nausea, vomiting, and 
metabolic acidosis. However, other chemicals are only harmful to the body at high 
concentrations. An example is calcium, which at excessive amounts is associated with renal 
disease. Microbial contamination can produce bacteremia and chronic inflammation in 
patients. Both health problems contribute to and complicate cardiovascular disease, the 
leading cause of death in dialysis patients (Coulliette, 2013).  
 It is important that system components are monitored on a regular basis, especially 
those areas at higher risk of contamination, because chemical and microbial contamination 
is a major threat to the safety of dialysis treatment. Chlorine is monitored before each new 
patient begins treatment, and after the carbon tank. The storage tanks and distribution pipes 
are monitored once per month for microorganisms and endotoxins. The dialysis machines 
are also tested monthly on a rotational basis. The need for constant monitoring of the 
existence of chemical, microbial, and endotoxins is to prevent outbreaks. Chemical and 
microbial contaminants have caused 13 and 20 outbreaks in the United States, respectively, 
as reported by the Center for Diseases Control (CDC). Chemical intoxication has caused 
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217 cases and 14 deaths, as was investigated by the CDC between 1960 and 2007. On the 
other hand, microbial outbreaks caused 375 cases and 2 deaths. There are many reasons 
why the outbreaks occurred. Chemical toxicity is a result of water treatment failures, such 
as incompatible dialysis solutions and distribution equipment and materials, and 
inadequate rinsing of dialysis systems after disinfection. Microbial outbreaks are cause 
mostly by improper disinfection- specifically inconsistent cleaning and disinfection of 
facility tap water and commercial deionizer resins, mixing an improper disinfectant 
solution, or not disinfecting the water system correctly when flow meter valves are open. 
Approximately half of the microbial outbreaks are associated with reuse of a dialyzer 
(Coulliette, 2013). However, with proper monitoring and reporting of the water treatment 
system, contaminants can be limited and kept under control. 
 The water treatment system is vital to ensure the safety and effectiveness of dialysis 
treatment. The risk of contamination is a major health concern for patients and must be 
taken seriously. With a proper water system design and following the water standards, in 
addition to frequent monitoring of the system, one can provide high quality water to 
dialysis patients. This treated water can then be taken in by the dialysis machine. The 
hemodialysis machine itself has major components that the blood must pass through to 
ensure the most effective and safe removal of fluid. Figure 23 shows how a typical 
hemodialysis machine looks.  
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Figure 23: Today's Typical Hemodialysis Machine 
Machine models vary depending on company, improvements, etc. However, the 
following significant components remain the same. First is the dialyzer, which is known as 
the artificial kidney of the dialysis machine. Along with the dialyzer is the blood pump, 
which moves the blood from the patient to the dialyzer and then back to the patient. This 
pump can operate at different flow rates that are adjusted depending on the patient and 
range between 200 to 600ml/min (Friedman, 2010). The third component of the 
hemodialysis machine is the dialysate pump. Its job is to move the dialysate into the 
dialyzer and take the ultra-filtrate out of the dialyzer. It is important to monitor and control 
is the flow rate of the dialysate, which is typically set from 500 to 800 ml/min, depending 
on the patient. The last two components are the arterial and venous pressure monitors and 
the alarms. The arterial pressure of the patient is taken before the blood reaches the blood 
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pump to ensure that there is the proper amount of suction of blood. The venous pressure is 
measured within the machine after the dialyzer to make sure there is the correct resistance 
on the venous side of the access point. Finally, the alarms are in place to make sure 
treatment is stopped if there are any problems throughout the process.  
2.3.3 The Treatment Process 
 Dialysis is not an easy process and can cause major health issues if done incorrectly. 
Therefore, the National Kidney Foundation: Dialysis Outcomes Quality Initiative 
established guidelines and restrictions to initiate hemodialysis. According to Present and 
Future Therapies for End-Stage Renal Disease, once a doctor detects loss of kidney 
function in a previously healthy person, they analyze two different laboratory criteria that 
will be used to decide if dialysis is the proper pathway for the patient. First, the doctors 
determine the patient’s Kt/V value, where K is clearance or urea, t is treatment time, and 
V is urea volume distribution. Kt/V measures the adequacy of treatment (NKUDIC). If this 
value is below 2 liters/week, then the patient is to be prescribed dialysis treatment. This 
value became the cutoff for receiving treatment because of the CANUSA, or Canada-USA 
study. This study was performed on 60 incident peritoneal dialysis patients and analyzed 
the morbidity and mortality of these patients. What they found was that, “over a two-year 
period, every 0.1 U/week increase in the total Kt/V was found to correspond to a 6% 
decrease in the relative risk of death. The total Kt/V and creatinine clearance values that 
corresponded to a 78% two-year survival rate were 2.1 L/week and 70 L/1.73 m2/week, 
respectively.”  
 Secondly, the doctors measure the “normalized protein equivalent of nitrogen 
appearance” or nPNA. The patient’s protein excretion is measured compared to their 
 45 
protein intake. A doctor will put a patient on dialysis if their nPNA value is below 
0.8g/kg/day (Friedman, 2010). It is important that these tests are done quickly and 
efficiently so that the patient can receive treatment as fast as possible. If the patient does 
not receive treatment fast enough their condition can worsen and hemodialysis may longer 
help. If a patient is diagnosed with chronic renal failure and needs to get hemodialysis 
treatment, the next step for the doctor is to prescribe the patient the type of dialyzer, 
frequency, blood flow, dialysate flow, composition of dialysate, and the total duration the 
patient will have to undergo treatment for. There are three different types of dialyzers to 
choose from. These are the coil dialyzer, the parallel plate dialyzer, and the most commonly 
used hollow fiber dialyzer. The hollow fiber dialyzer is a cylindrical tube filled with 
thousands of hollow fibers through which the blood flows in and the dialysate flows 
around. The other major part of the dialyzer is the dialysis membrane, which there are also 
three types to choose from. The first is cellulose, the second is modified cellulose, and 
lastly is the most common, synthetic membrane  
All of these variables are prescribed in order to get an adequate urea clearance to 
help the patient. In other words, different types of dialyzers will change the clearance of 
urea from the blood. Also if the treatment lasts longer, then the amount of urea cleared 
from the blood will vary. For a new dialysis patient, the doctors are cautious and limit the 
duration of treatment, volume removed, and amount of urea cleared so that the patient will 
not acquire disequilibrium syndrome (Friedman, 2010). This often occurs when people 
with chronic renal failure start off with aggressive treatment. 
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The aforementioned dialyzer is one of the most important components of the 
dialysis process. Inside of this cylindrical tube is the blood compartment, the dialysate 
compartment (which is pre-prescribed for each patient), and thousands of hollow fibers. 
There are approximately 10,000-20,000 fibers in a typical dialyzer and these fibers have 
pores, which allow for the removal of waste from the blood (Azar, 2013). The fibers are 
held in place by the potting material near both headers located at the top and bottom of the 
dialyzer. The potting material is usually made from the polyurethane group and ensures a 
secure connection of the fibers in the dialyzer (Azar, 2013). The headers serve as the area 
between the two blood ports and the middle of the dialyzer where the fibers are located. 
There are three different types of dialyzers to choose from: the coil dialyzer, the parallel 
plate dialyzer, and the hollow fiber dialyzer. The coil dialyzer, which was an early design 
of the dialyzer, has since been replaced with more efficient designs, such as the parallel 
plate dialyzer (Types of Dialyzers, 2014). The parallel plate dialyzer allows for thinner 
blood and dialysate flow channels due to the parallel membranes layered in the dialyzer. 
Lastly, the hollow fiber dialyzer is a cylindrical tube filled with thousands of hollow fibers 
that the blood flows through and the dialysate flows around (Kiaii, 2013). This design is 
the most efficient and therefore is the most commonly used. The hollow fiber dialyzer and 
its main parts are shown in Figure 24.  
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Figure 24: Hollow Fiber Dialyzer 
The hollow fibers bundled inside of the dialyzer are responsible for the removal of solutes 
from the blood. They are porous and therefore allow molecules to pass through. There are 
three specific processes that occur within the dialyzer to remove these molecules. The 
process through which a certain molecule is filtered out of the blood by depends on the size 
and molecular weight of that molecule. Table 2 displays the size range and classification 
of some common solutes that are removed during the process of hemodialysis. Specifically, 
small molecules are removed through diffusion, middle molecules are removed through 
convection, and large molecules are removed through adsorption. 
Table 4: Classification of Solutes 
Size Category Example of Solutes Molecular Weight 
Range (Daltons) 
Small Molecules Urea, Creatinine, Phosphate <500 
Medium-Sized 
Molecules 
Vitamin B¬12, Inulin, Vancomycin, β2-
microglobulin 
500-15,000 
Large molecules Myoglobin, Albumin, Transferrin, 
Retinol-Binding Protein, EPO 
>15,000 
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Diffusion is the main process that occurs inside of the dialyzer that contributes to 
the filtration of waste. Diffusion is the movement of particles from an area of high 
concentration to an area of low concentration. In the case of hemodialysis, small molecules 
in the blood, such as urea, flow across the concentration gradient from the blood 
compartment to the dialysate compartment. This is because the blood is more concentrated 
than the dialysate, containing the excess waste and toxins that need to be filtered out. The 
process of diffusion within a dialyzer is demonstrated in Figure 25. As shown, the blood 
flows on one side downward through the dialyzer while the dialysate flows on the opposite 
side upward through the dialyzer. These directions of motion represent a countercurrent 
flow which maximizes the concentration gradient within the dialyzer (Hemodialysis, 
2014). 
In addition to the process of diffusion is the process of convection within the 
dialyzer. Convection is the movement of middle molecules from the blood compartment to 
the dialysate compartment. This movement occurs because of pressure differences in the 
compartments of the dialyzer. The blood within the dialyzer has a negative pressure while 
the dialysate has a positive pressure. Middle molecules also travel through convection 
because of the solvent drag that results from the flow that the small solutes permeating 
across the membrane create (Azar, 2013). While diffusion can only remove small 
molecules from unclean blood, convection is responsible for filtering out middle 
molecules. In addition to diffusion, Figure 25 also displays the movement of solutes during 
the process of convection in the dialyzer.  
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Figure 25: Diffusion and Convection in Dialyzer 
 The last process that takes place inside of a dialyzer is adsorption. Adsorption is 
less common than diffusion and convection because its occurrence depends on the 
composition of the dialyzer membrane. For example, adsorption will only occur in 
dialyzers with large enough pores in the membrane to allow for large solutes to pass 
through. This process is when large molecules, such as albumin, adhere to the dialyzer 
membrane. Unlike diffusion and convection, adsorption can only filter out proteins from 
unclean blood (Azar, 2013). The amount of large solutes that are removed from the blood 
depends on the affinity gradient of the membrane. Furthermore, the affinity gradient is 
determined based on ionic, hydrophobic, and van der Waals interactions (Rimmele & 
Kellum, 2010). 
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There are many factors that affect the efficiency of solute clearance within a 
dialyzer. Some of these factors are blood flow rate, dialysate flow rate, surface area of the 
dialyzer, pore size, and length of dialysis treatment. In most cases, the blood flow rate 
within a dialyzer is maintained at a rate of 200-500 mL/min but can vary depending on the 
patient (Azar, 2013). If the blood flow rate is low, then the rate of solute clearance will be 
low compared to a higher blood flow rate which would result in a higher rate of solute 
clearance. Additionally, the size of a certain solute will also affect its reaction to varying 
blood flow rates. Along with the blood flow rate influencing solute clearance during 
dialysis is the flow rate of the dialysate. The flow rate of dialysate is maintained at a 
minimum of 500 mL/min. However, high-flux dialyzers, which are dialyzers that contain 
a high-porosity membrane for more efficient solute removal, will require a dialysate flow 
rate of approximately 700-800 mL/min (Azar, 2013). Correspondingly to an increase in 
blood flow rate, an increase of dialysate flow rate will increase the rate of solute clearance 
in the dialyzer. Although it can be more effective for solute clearance, opting for an 
increased dialysate flow rate will result in a more costly treatment because this requires 
more dialysate concentrate per dialysis treatment. 
The surface area of a dialyzer also influences the rate of solute clearance during the 
treatment process. Most dialyzers range in a surface area of 0.8-1.4 m2 but can be as large 
as 2.6m2 or as small as .3m2 (Azar, 2013). The larger the surface area of the dialyzer, the 
faster the rate of solute clearance that occurs if all other factors are kept the same. 
Furthermore, the length of the treatment process is the greatest determining factor of solute 
clearance because understandably, the longer the process is performed for, the larger the 
amount of waste that can be removed from the blood. All of these factors can be accounted 
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for mathematically in order to compare the exact changes they may have on solute 
clearance. Specifically, the rate of movement of molecules per unit time can be calculated 
using the formula 
𝑑𝑛
𝑑𝑡
=  −𝐷𝐴
𝑑𝑐
𝑑𝑥
                                                                 (5) 
where 
𝑑𝑛
𝑑𝑡
 is the rate of movement of molecules per unit time, 𝐷  is Fick’s diffusion 
coefficient, 𝐴 is the area of the boundary through which the molecules move, and 
𝑑𝑐
𝑑𝑥
 is the 
distance through which the molecules move. This equation combines the factors that affect 
the solute clearance so that exact numbers may be calculated. 
The fibers within the dialyzers can be produced using a variety of materials. The 
two main groups of membranes used for the fibers are cellulose membranes and synthetic 
membranes. Furthermore, cellulose membranes can be broken down into groups of 
unsubstituted cellulose or substituted cellulose. With unsubstituted cellulose membranes, 
the cellulose is produced using cotton and they contain many free hydroxyl groups within 
the cellulose polymer. These free hydroxyl groups are able to activate serum complement 
proteins which in turn activate leukocytes and cause bioincompatibility. With substituted 
cellulose membranes however, there is a chemical substitution of acetate or similar 
molecules for these free hydroxyl groups (Azar, 2013). Therefore, modified cellulose 
membranes are created.  
 Synthetic membranes can be broken into regular synthetic membranes, or more 
recently, bioactive synthetic membranes. Synthetic membranes are created from non-
cellulose synthetic polymers. Compared with cellulose membranes, synthetic membranes 
are not as strong. However, these types of membranes are more biocompatible. Some 
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examples of the polymers used for synthetic membranes are polyacrylonitrile, polyamide, 
polymethylmethacrylate, polysulfone, or polycarbonate. There has been some innovation 
with bioactive synthetic membranes, although they have not proven to be more efficient 
yet. Thus far, there are polysulfone vitamin E-coated membranes and polyacrylonitrile 
heparin-grafted membrane. The former has proven to reduce oxidative stress markers for a 
dialysis patient while the latter has been able to decrease anticoagulant necessities 
throughout a dialysis treatment (Azar, 2013). 
Synthetic membranes are most widely used due to their biocompatibility and 
variety. These membranes can be used to produce low-flux or high-flux dialyzers. Low-
flux dialyzers are dialyzers that have small pores on the fibers, which does not allow for a 
fast blood flow rate. High-flux dialyzers enable a highly efficient dialysis treatment. 
However, there can be disadvantages to high-flux dialyzers, as well. For example, they 
increase the risk of hypotension for the patient. Hypotension is when a patient develops 
low blood pressure within their arteries during treatment. This is the opposite of 
hypertension, or high blood pressure. Additionally, a phenomena called backfiltration will 
inevitably happen with the use of high-flux dialyzers. Backfiltration is the flow of fluid 
from the dialysate part of the dialyzer to the blood part. It occurs because of pressure 
differences within the dialyzer, which are more drastic in high-flux dialyzers. When this 
phenomena occurs, it is dangerous for the patient once the blood is returned, especially if 
the patient is exposed to high-flux dialyzers frequently (Azar, 2013).  
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CHAPTER 3. REDUCING DELAYS IN THE DIALYSIS PROCESS 
3. Introduction 
 Once all of the preceding background research was conducted, the project team was 
able to recognize two types of factors that contribute to the length of treatment time: those 
which are intentional components of the dialysis process, and those which are potential 
mishaps. The team set out to find ways to shorten treatment time in both such aspects. This 
goal was accomplished by first identifying the sources of delays within the system, then 
creating various iterations of proposed designs to address said delays, analyzing and 
comparing the designs to available options. The team also proposed various alternative 
recommendations and solutions to improve current practices. This chapter details the work 
done and procedures followed throughout the course of the project, and an explanation of 
results and observations. 
3.1 Reducing Treatment Time Delays 
There are various factors that contribute to the elongation of the hemodialysis 
treatment process. Furthermore, some factors may create safety concerns for the patient 
throughout the treatment. After the team investigated causes for delays and safety concerns, 
solutions could be formulated and analyzed. 
3.1.1 Cartridge Design 
Determined through our research, a separate cartridge is beneficial to the 
hemodialysis process when added to a dialysis machine. The cartridge is used to house the 
components for the blood purification system. The blood purification system involves the 
extracorporeal circulation of contaminated blood through a semi permeable membrane. A 
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disadvantage to most dialysis machines is that the blood purification system is composed 
of a myriad of tubes that comprise the fluid pathways. This results in an increased risk for 
leakage and breakage. The Fresenius 2008K2 dialysis machine, modeled in Figure 26, uses 
a modular design that allows for flexibility in treatment applications, such as single needle 
and double needle dialysis.  
 
Figure 26: SolidWorks® CAD Model of Fresenius 2008K2 
The team also created SolidWorks® models of all of these modular components, 
which can be seen in Appendix G. The modular system allows for the use of disposables. 
However, one can see in Figure 27 that the modular system is bulky and contains empty 
spaces when opened up. Additionally, the modular system must be unscrewed in order to 
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remove a single modular, thus increasing the time required to rearrange or add additional 
modular prior to a treatment process.   
 
Figure 27: Pictures from the Modular Fresenius 2008K2 Dialysis Machine 
The cartridge, which is invented by Barry N. Fulkerson and Russell T. Joseph, is shown in 
Figure 28. This cartridge is recommended by the team to be incorporated in future dialysis 
machines. The cartridge is composed of sensors, pumps, and disposables.  
 
Figure 28: Illustration of the Current Cartridge 
Figure 29 can be referred to throughout this explanation. The numbers refer to the 
molded flow paths containing disposable tubes for the blood, dialysate, waste fluids, and 
substitutions fluids. 
 56 
 
Figure 29: Flowchart of the Cartridge 
The following sensors can be incorporated in the cartridge: arterial and venous 
pressure monitors, air detectors, blood leak detectors, and flow meters. The sensors are not 
required but instead are optional. They can be inserted into the cartridge by a concave 
molding. Therefore, allowing for different sensors to satisfy different needs and thus 
improving the safety of treatment. The cartridge houses two pumps, a blood pump and a 
waste pump. For the current invention, the blood pump tubing is Tygon brand, formulation 
S-50-HL, with dimensions of 1/8” Inner Diameter by 3/16” Outer Diameter by 1/32” wall 
thickness. The waste pump tubing is of the same brand but the dimensions are 3/32” Inner 
Diameter by 5/32” Outer Diameter by 1/32” wall thickness. These dimensions and brand 
of tubing are not required, but were however included as a possible solution. The blood 
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volumetric pump draws blood into the cartridge through the blood inlet port and flow path 
1. The blood volumetric pump pumps blood into the dialyzer through flow path 2. The 
waste volumetric pump draws waste out of the dialyzer through flow path 4 and is pumped 
out of the cartridge through flow path 5.  
The material that was selected for the modified cartridge was of brand Tecapeek 
MT, which is a semi-crystalline, high performance thermoplastic. This material is used in 
the medical field in applications such as surgical instruments, surgical containers, pump 
housing, sensor housing, and sterilization containers. Tecapeek MT is FDA and ISO 10993 
compatible, as well as USP Class VI biocompatible. This material can be exposed to 
limited contact to blood and tissue up to 24 hours. Along with being biocompatible, 
Tecapeek MT has the following properties, good wear resistance, chemical resistance, and 
excellent gamma radiation resistance. Additionally, Tecapeek MT can withstand Eto and 
Steam sterilization, which is important for disinfection of the cartridge. The material is well 
suited for the modified cartridge for it is available in both red and blue for the color-coded 
manifold (Tecapeek MT, 2008). 
The brand of tubing that we recommend for the cartridge is Streamline from 
NxStage. The blood set tubing, labeled 1, 2, and 3, is where the blood enters the cartridge 
through the blood inlet port and goes to the dialyzer before returning back to the patient 
through the blood outlet port. The tubing should be of a specific length and diameter 
capable of supplying a blood flow of 50 mL/minute. The blood set tubing, labeled 4 and 5, 
removes waste from the dialyzer and brings it to the waste out port. This tubing should be 
capable of supplying a blood flow of 8.33 mL/minute. The molded flow paths are 
incorporated into a single portable composite manifold. Integrating color-coded flow paths 
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is greatly beneficial because they clearly represent the blood and waste paths, making 
connecting of tubes easier. The SolidWorks model in Figure 30 shows the modified 
cartridge with the tubing in place and the color-coded manifold.  
 
Figure 30: SolidWorks CAD of the Modified Cartridge 
A dialyzer is shown in the hemofilter cartridge of the aforementioned 3D model. 
The blood is cleansed of toxins as it passes through the dialyzer. The clean blood then 
follows flow path 3 and exits through the blood outlet port. An example of possible 
specifications of the hemofilter is shown in Table 3 (Fulkerson and Joseph, 2013). 
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Table 5: Possible Specifications for a Hemofilter in the Cartridge 
Component Specification 
Membrane Surface Area (m2) ≤ 0.1 
Prime Volume (ml) ≤ 10 
Molecular Weight cut-off (Daltons) 65000 
Pressure Drop3 (mmHg) ≤ 50 (Ob = 50 ml/min) 
Max Transmembrane Pressure (mmHg) ≥ 500 
Overall Unit Length (cm) 12 - 15 
Filtration Rate 8 – 10 ml/min @100 mmHg 
Tubing Connections 
Blood Male Luer 
Filtrate Slip Fit (straight) 
Sterilization ETO or gamma 
Preferred Membrane Material Polysulfone  
Housing Material Polycarbonate 
Potting Material Polyurethane 
 
Figure 31 shows an enlarged, detailed view of the manifold of the present invention 
with color-coded pathways for the flow paths carrying blood and waste. The connection 
ports are molded into the module for connecting to the pumps and the hemofilter cartridge 
through the use of Luer connections and tubing.  
 
Figure 31: Enlarged View of Flowpath Manifolds 
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The modified cartridge with Streamline tubing and the colored flow path manifold is 
recommended to be used in dialysis machines. The manifold system with color-coded 
pathways improves upon treatment by decreasing the risk of disconnection, misassembly, 
and leakage compared to prior dialysis machines. Assembly and cleaning segments of the 
treatment process would be faster with color coded flow paths, disposables, and concave 
moldings to quickly insert components into the cartridge.  
 Figure 32 shows a possible configuration of the modified cartridge in the Fresenius 
2008K2 machine. The cartridge simplifies the tubing pathways, minimizes the overall bulky 
components, and allows for ease of assembly due to the color-coded manifolds.  
 
Figure 32: Cartridge Incorporated into Fresenius 2008K2 
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The cartridge replaces the modular system by incorporating all of the components of the 
extracorporeal circuit. Therefore, the modified cartridge is intended to decrease the 
delays associated with dialysis treatment and should be integrated into future dialysis 
machines.   
3.1.2 Needle Fixture Design 
 Dislodgement is a very serious and potentially deadly problem in dialysis. Should 
any needle ever become disconnected from the patient during treatment, it will cause a time 
delay, however venous needle dislodgement (VND) is a lot more serious, as this is the 
needle that is returning the cleaned blood to the patient. There is an incidence rate of about 
400 patients per year. When the venous fistula needle becomes separated from the access, 
there is a drop in venous blood pressure and rapid blood loss. At standard blood flow rates, 
it usually takes just minutes for a patient to lose 40% of their blood volume, which is the 
amount that causes hemorrhagic shock. Though dialysis machines have sensors and alarms 
to alert the staff, the drop in venous pressure is often not significant enough to trigger these 
means, and so other steps must be taken.   
 In addition to the blood pressure monitors on the machine, there are a number of 
other monitors and sensors that are available as add-ons, such as moisture monitoring pads 
and blood detection devices. Unfortunately, each of these safety measures has significant 
downfalls and has been found incapable of detecting small volumes, which renders them 
useless as early alerts. For this reason our project aimed for preventing dislodgement rather 
than detecting it after the fact. The team has designed a fixture to help hold fistula needles 
in place and prevent dislodgement. This fixture is shown in Figure 33 and takes the form 
of a band that can be wrapped around a patient’s arm. 
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Figure 33: Armband Needle-Holding Fixture 
 The darker, outer wings are modeled with a canvas material, but could be made of 
any flexible, comfortable material. These wings would attach with Velcro. In the middle 
of the arm-band, there is a rigid triangular plastic piece, with a clamp attached to the 
bottom. This clamp will be the portion of the arm-band that actually holds the needle. The 
purpose of the triangular piece is to protect the needle and the clamp from possible outside 
factors. This needle-holding fixture can be snapped onto the fistula needle after 
cannulation, and the canvas wings can be comfortably wrapped around the arm and 
fastened on the other end. The clamp is designed with a flexible plastic material that can 
adjust to suit the range of outer diameters that it would encounter between 1.27 and 2.108 
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mm. The reason that the clamp is below the triangular part instead of above is because the 
fistula needle must be flattened against the patient’s skin during cannulation. 
3.1.3 New Tubing 
 The machine the team worked with is the Fresenius 2008K2 model, which uses a 
brand of tubing called ReadySet. This tubing is made with several materials, with the most 
significant being polyvinyl chloride (PVC). This tubing contains the plasticizer 
diethylhexylphthalate (DEHP) to allow malleability. A risk with this type of plasticizer is 
that small amounts of it break off and flow into the blood stream. There are two sets of 
tubing involved in the hemodialysis treatment process: the arterial tubing and the venous 
tubing. The arterial tubing is connected directly to the patient and draws the blood from the 
patient into the machine to be cleaned. The venous tubing is how the cleaned blood is 
brought back to the patient. Both of these tubing sets are fed through the machine in a loose 
configuration to allow the patient to move around during treatment without dislodging the 
needle or other components of the machine. Additionally, these tubing sets are equipped 
with side branches that consist of anticoagulants, pressure monitors, and drip chambers. 
These side branches ensure the patients’ safety and effective cleaning process. 
  ReadySet tubing is currently used in the machine for many reasons. Most 
importantly, it is used because it is medically safe for the patient. The geometry, as well as 
the blood pumps, also allows for the correct blood flow rate (BFR) for the patient 
throughout the treatment process. Although the tubing does not directly control this fluid 
characteristic, the size of the tubing does differ from patient to patient altering the BFR. 
For example, the venous pressure will vary depending on the diameter of the bloodline 
tubing. Pediatric patients use a narrow tubing diameter, which in turn affects the overall 
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extracorporeal blood volume. The diameters for an adult patient and the diameters for a 
pediatric patient vary.  
Considering all the variables of the bloodline tubing that can contribute to sources 
of delays in the dialysis treatment, we researched possible solutions to implement into the 
Fresenius 2008K dialysis machine. We focused on reducing the tubing length, making the 
tubing more lightweight, changing to a safer material, and maintaining an efficient flow 
rate. The first delay that is commonly encountered in the dialysis treatment process is the 
time it takes for the blood to travel through the machine and return to the patient. The 
tubing is lengthy, which causes “spaghetti loops” inside of the machine. A “spaghetti loop” 
is a term given to excess tubing that drapes down and is loose along the path that the blood 
travels. An example of “spaghetti loops” in the machine is shown in Figure 34.  
 
Figure 34: Excess Tubing, “Spaghetti Loops” 
 There is some tubing hanging below components and in some cases even hangs 
below the machine, making it a safety hazard if the machine has to be moved. This delays 
the process for several reasons, one being the travel time. To validate that this aspect of 
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the tubing could be altered, we researched other types of tubing that are being used in the 
dialysis field and compared it to ReadySet tubing. The length of the tubing coincides with 
the volume of the extracorporeal circuit, which is where the blood travels through in the 
machine. Therefore if the tubing is lengthy and has a large diameter the overall volume 
and space it takes up will cause the machine to be very bulky and heavy. This produces 
delays in the treatment process because the set up and clean up segments are prolonged.  
 The longest part of dialysis is the actual treatment time. If the tubing is less lengthy, 
the cleaning and mounting process will not take as long. The next source of delay that 
greatly impacts the time a patient has to endure treatment is the splashing of blood and 
formation of micro-air bubbles within the drip chamber. As the blood drips into the 
chamber, it can create small air bubbles, which then pass through an air bubble detector, 
causing the machine to sound an alarm and stop treatment. Air bubbles can be very 
dangerous for the patient and therefore must not be passed back into the patient’s 
bloodstream. According to Streamline, Medisystems, A Nxstage Company, it is very 
common for dialysis treatments to result in infusion of air bubbles into the patient’s 
bloodstream, causing inflammation, air embolism, and lung damage. The monitoring of air 
bubbles within the machine slows the overall dialysis treatment time. Lastly, the excess 
medical waste that is produced from the treatment process contributes to delays in the 
cleanup portion. With more waste, we found that the doctors or nurses spend more time 
cleaning up after the treatment process, which can extend the treatment process for the 
patient.  
 Throughout this project, we focused our research on ways to reduce the time it takes 
for a patient to receive dialysis treatment. Specifically we looked at how the tube can be 
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modified to reduce the travel time. From our research we found that a brand of tubing called 
Streamline was being tested and used for NxtStage dialysis products. NxtStage has 
developed a portable dialysis machine that is 15x15x18 in, weighs approximately 75 
pounds, and still maintains the same flow rate of about 600mL/min. This, compared to the 
Fresenius 2008K with dimensions of 45in. x20in. x20in. and weight of about 154 pounds, 
was accomplished by using Streamline tubing (2008K User’s Guide, 2012). 
 After comparing the benefits of Streamline tubing to ReadySet tubing, we 
concluded that in order to reduce the delays of the dialysis treatment, it would be a great 
improvement to implement Streamline tubing to Fresenius model machines. There are 
several reasons why Streamline is so innovative. First, the design of this brand of tubing 
incorporates airless components. In other words, it eliminates the air-blood contact by 
replacing the typical drip chambers, which uses an air gap for pressure monitoring, with an 
airless arterial and venous pressure measurement, known as Pressure Oscillating 
Diaphragm, “POD”. As the blood travels into the POD, there is an internal flexible 
diaphragm that communicates pressure to the sensors within the machine. Figure 35 shows 
a close up view of the POD.  
 
Figure 35: Venous Pressure (POD) 
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 The research yielded a common area for delays in the drip chambers and tubing 
was the air-blood contact. By eliminating this interaction, there will be fewer delays 
relating to the formation of air bubbles and the patient will remain safer. Along with the 
airless POD, Streamline also replaces the venous chamber that ReadySet tubing uses with 
an airless venous “vortex” chamber. This design is advanced because it prevents any 
splashing of blood or stagnation of blood within the compartments. The blood enters with 
a horizontal, vortex-like flow and fills the chamber completely. A venous bubble trap 
filter that is intended to reduce clotting is also inside the chamber. The vortex chamber is 
shown in Figure 36, along with a close-up of the filter within. 
 
Figure 36: Vortex Chamber & Filter 
 These components are designed to improve the safety of the patient by eliminating 
the air to blood contact that result in delays in the dialysis treatment process. It provides 
safe travel of the blood throughout the machine so that the patient does not have air bubbles 
form within the bloodline, leading to serious health risks. 
 Next, Streamline has improved the tubing design inside of the machine. The tubing 
length was reduced, lessening the “spaghetti loops” that conventional tubing have while 
still be compatible with the Fresenius 2008K dialysis machine. Overall, it reduces the 
extracorporeal blood volume, lightens the weight of the machine, and simplifies the tubing 
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design. Table 4 shows the reduction of each component and the impact of this 
improvement.  
Table 6: Streamline Versus Traditional Tubing 
Conventional 
Bloodline Layout 
Streamline 
Layout Change 
Clinical and Operational 
Impact 
Extracorporeal 
Blood Volume: 
                 143-165mL 
15-35% lower  Less blood exposure to plastic 
 Lower saline priming volume 
 Less “spaghetti” designed for easier 
setup, teardown and troubleshooting 
Set Weight:  
                 0.64-0.70lb 
35% lower  Designed for lower disposal costs 
 Less landfill usage 
 Fewer red bags to close and discard 
Packaging Volume: 
               24 sets/case 
33-50% lower  Lower storage space requirements 
 Reduced packaging waste 
  
From this table, it is clear that incorporating Streamline tubing in Fresenius model 
machines will reduce much of the waste and time it would take to clean and dispose of the 
used materials. This will result in a shorter treatment time for the patient. The reduction of 
“spaghetti loops” and excess tubing is important because it decreases the chance of 
something getting caught on the tubing and tugging on the machine and patient, which can 
be very dangerous. Figures 37(A) and 37(B) show a comparison of ReadySet tubing and 
Streamline tubing within the same machine.  
 
Figure 37: (A) Machine with ReadySet Tubing, (B) Machine with Streamline Tubing 
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 As can clearly be seen, the ReadySet tubing has lengthy loops and excess tubing 
hanging outside of the frame of the machine. On the other hand, Streamline has reduced 
the amount of tubing used and simplified the path in which the blood travels. Due to the 
laminar flow of the blood in the in the bloodline tubing, the length and angle of bend in the 
tubing also plays a crucial role in the blood flow rate. Simplification of the blood travel 
path will reduce the amount of severe angles the tubing takes to bring the blood from one 
component to the next. Pressure and BFR are very vital to patients’ safety and the efficiency 
of the dialysis treatment. As we researched more about the possible delays in the dialysis 
process, we found that increasing the flow can decrease the amount of time it would take 
for the overall treatment process.  
Streamline also impacts the clinical outcomes, which helps the efficiency of the 
treatment process. In order to improve the safety of patients during dialysis, we researched 
what could cause health problems and side effects. One health risk that Streamline 
addresses is the unwanted side effects of heparin, the anticoagulant administered in most 
dialysis treatments. In some cases, patients can get heparin-induced thrombocytopenia, 
allergies, osteoporosis, or excessive bleeding. Streamline was designed so that the doctors 
would not have to give the patient as much heparin as usual. Typically, patients would 
receive about 0.75-1.75mL more heparin if using conventional tubing. This reduction, 
according to Medisystems, reduced the clotting and improved rinsebacks.  
Another improvement in clinical use for Streamline is the improvement in the 
arterial pressure and increase in blood flow. Dialysis treatment standards usually only allow 
for the arterial pressure to be improved by changing the patient’s vascular access or by 
lowering the blood flow. Streamline tubing allows for the machines to work at a lower 
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arterial pressure, which improves the hemodynamics and lowers the turbulence, or 
movement within the bloodlines. Figures 38 and 39 show two graphs of the arterial pressure 
improvement and blood flow improvement based on clinical experience.  
 
Figure 38: Arterial Pressure Improvements with Streamline 
    
 
Figure 39: Blood Flow Improvements with Streamline 
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From these graphs, it is clear that by using Streamline the blood flow rate can be raised by 
50-100mL/min without any negative effects on the patient. This will not only lead to a 
faster dialysis treatment, but also has a positive effect on the Kt/V, the minimum treatment 
urea ratio. By increasing the blood flow, the doctors can then increase the prescribed 
dialysis doses.  
 Implementation of Streamline tubing into Fresenius dialysis will greatly improve 
treatment in several aspects. The first is reducing the size of the extracorporeal blood 
volume and simplifying the tubing design within the machine. The Streamline innovation 
of airless components also increases the safety of the patient by reducing the chance of air 
bubble formation, which can cause serious health problems. Reducing the travel time of 
the blood will also help in decreasing the delays associated with the overall time it takes to 
complete treatment. Additionally, Streamline increases the blood flow and the dialysate 
prescription, resulting in a more effective treatment. Streamline tubing is a new tubing 
system designed to improve the dialysis efficiency and should be used in Fresenius dialysis 
machines and eventually all dialysis machines. The streamline tubing is compatible with 
the cartridge design. 
3.2 Recommendations 
 This chapter discusses the suggestions that the team proposes for helping to 
reduce time delays in the hemodialysis treatment process. The first section presents the 
recommendations for needles and access points, while the second and third present 
recommendations for the dialyzer and water treatment system, respectively. Our 
recommendations are based on extensive research of the hemodialysis process and were 
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tested for effectiveness by comparison to the literature and previous efforts made towards 
reducing treatment delays.  
 
3.2.1 Preventing Treatment Delays Associated with Needles and Accesses 
The proper insertion, securement and removal of the fistula needle are very 
important, as explained in chapter two. One setback that can lead to prolonging dialysis 
treatment time is posterior wall infiltration. As previously mentioned, to prevent this 
accident, the nurse should first rotate the fistula needle 180° during the cannulation process. 
Rotating the needle gives the nurse a chance to pause once the needle is within the first 
wall of the access, which decreases the likelihood of infiltration of the posterior wall. In 
the event that infiltration still occurs however, the course of action depends on the 
conditions of the situation.  
If the patient has not yet received heparin, the needle should be pulled out and 
pressure should be applied to the exit site by placing two fingers along the access, covering 
at least a one-inch area. If, however, the patient has already received heparin at the time of 
infiltration, the puncture site must be carefully assessed. If the needle site remains stable 
with no increase in size or swelling, it is safe to keep in place for the duration of the dialysis 
treatment, but ice should be applied over the infiltration site. If a solid swelling is observed, 
the needle should be removed and digital pressure should be applied. It is important to note 
that pressure should never be applied while the needle is inside the patient. If the needle 
had to be removed due to infiltration, a new needle should be used to perform cannulation 
and a new spot should be chosen as far away as possible. Infiltration is one delay for which 
the administering nurse must be properly trained. 
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  Dislodgement is a very serious and potentially deadly problem in dialysis. Should 
any needle ever become disconnected from the patient during treatment, it will cause a time 
delay, however venous needle dislodgement (VND) is a lot more serious, as this is the 
needle that is returning the cleaned blood to the patient. There is an incidence rate of about 
400 patients per year. When the venous fistula needle becomes separated from the access, 
there is a drop in venous blood pressure and rapid blood loss. At standard blood flow rates, 
it usually takes just minutes for a patient to lose 40% of their blood volume, which is the 
amount that causes hemorrhagic shock. Though dialysis machines have sensors and alarms 
to alert the staff, the drop in venous pressure is often not significant enough to trigger these 
means, and so other steps must be taken. 
 To prevent needle dislodgement without the use of the needle-holding fixture 
design, it is important to properly care for the access site prior to cannulation. If the site is 
not allowed significant time to dry after it has been cleaned during prep, the bandages are 
more likely to slip off. To help pacify the effects of dislodgement once it occurs, the first 
recommendation of this project team is consistent monitoring. It is usually the case when 
dislodgement becomes fatal that the patient was asleep under a blanket and no one noticed 
the blood spillage. Nurses at dialysis centers and in the home should make consistent 
rounds and check on any covered or sleeping patient.  
 Another source of delay related to the needles and access points is the formation of 
a pseudoaneurysm at an access graft because it can limit the life of the graft and require 
the creation of a new access, which takes time to mature. A pseudoaneurysm is a solid 
swelling of clotted blood that forms outside the arterial wall and so is contained by the 
surrounding tissues. They are usually caused by repeatedly puncturing the same limited 
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area on an access with the fistula needle. Obviously, the best way to prevent the formation 
of a pseudoaneurysm would be for the nurse to avoid repeatedly cannulating the same areas 
of an access. Once again, this type of delay is one that a nurse or doctor would treat best. 
Traditional treatment includes surgically extracting the pseudoaneurysm and replacing the 
entire graft, perhaps one made with a different material. Access sites can also provide 
another source of treatment delays. Dialysis accesses can fail to mature but doing fistula 
hand-arm exercises can help. Ball squeezes, thumb-to-fingertip touches, hammer curls, 
bicep curls and clothes-pin grasps are all particularly advantageous. These exercises should 
be done before and after the fistula or graft surgery, and continued until the access is fully 
developed. 
3.2.2 Suggestions to Minimize Delays Associated with the Dialyzer 
 
As previously mentioned, the dialyzer can contribute greatly to the lengthiness of 
the hemodialysis process. Through previous research and tests, dialyzer characteristics 
have been studied since the creation of the hollow fiber dialyzer. The extensive research 
investigated on this aspect of the hemodialysis treatment process has enabled us to 
recommend the best options to ensure that each dialysis session can be optimized 
depending on the patient. There are many factors that contribute to the length of treatment 
and resulting delays of each dialysis session, such as the choice of dialyzer. This aspect of 
the dialysis process can be difficult as the dialyzer is essentially the “artificial kidney” of 
the procedure and is ultimately responsible for the removal of toxins from the blood. These 
performance characteristics are responsible for the amount of toxins that will be cleared 
out of the blood. However, it is crucial to rid the blood of wastes in addition to minimizing 
the length of each treatment. Therefore, we have investigated each component of the 
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dialyzer that may present delays to ensure that this step of the process is both efficient and 
time-reducing.  
 One delay that can be encountered in current dialyzers is a phenomenon called 
backtransport. This term describes two different occurrences- backdiffusion and 
backfiltration. Backdiffusion refers to the movement of bicarbonate from the dialysate 
compartment of the dialyzer to the blood compartment and is caused by the concentration 
gradient. This can happen in any type of dialyzer and is inevitable. However, backfiltration 
can be more dangerous if it occurs frequently. Backfiltration is the movement of fluid from 
the dialysate compartment to the blood compartment through convection. This is caused 
by the differences in pressure within the dialyzer during the dialysis process. At the start 
of treatment, the pressure of the blood inlet is always higher than that of the dialysate inlet. 
However, during treatment there is a pressure drop along the length of the dialyzer. The 
result is that the dialysate compartment has a positive pressure while the blood 
compartment has a negative pressure. This results in movement of the fluid in the dialysate 
side to the blood side in an attempt to equalize the pressure gradient. The backfiltration 
phenomena is not likely to occur in low-flux dialyzers. However, this occurrence is 
inevitable while using a high-flux dialyzer. This is because high-flux dialyzers are more 
inclined to have larger pressure differences between the two compartments and therefore 
are prone to more frequent backfiltrating. This is dangerous for the patient and if one should 
be exposed to high-flux dialyzers often, they can develop long-term health effects or even 
death (Azar, 2013). Therefore, we do not recommend the use of high-flux dialyzers even 
though they can rid the blood of toxins more quickly than low-flux dialyzers. 
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Another aspect of the dialyzer that may contribute to delays during the 
hemodialysis process is the chosen flow rates for each patient. These flow rates refer to the 
blood flow rate as well as the dialysate flow rate. The goal of reducing delays pertaining to 
the flow rates is to optimize the flow to be most efficient while still keeping rates safe for 
the patient’s heart. We determined optimal flow rates depending on certain factors, such as 
area of the boundary through which the molecules move. Ideal flow rates work together 
with the optimization of the tubing and tubing paths in order to complete each treatment in 
an efficient way. Once the proper flow rate is determined, the clearances of certain toxins 
can be calculated using various formulas. The inlet flow rates of the blood and dialysate 
were calculated. These flow rates were optimized but it still must be kept in mind that each 
patient is different and the flow rates will vary accordingly. In general, a faster dialysate 
flow rate will increase the rate of diffusion of urea from the blood compartment to the 
dialysate compartment within a dialyzer (Azar, 2009). 
 Lastly, a common delay encountered within dialyzers during hemodialysis is the 
interference of diffusing particles with the convection of other particles and vice versa. In 
other words, these processes are both occurring at the same time within the dialyzer, and 
therefore, they have effects on each other. As diffusion occurs within the dialyzer, large 
solutes tend to accumulate on the membrane surface because they cannot permeate through 
diffusion. This can prevent some of the middle molecules from being removed through 
convection as the large molecules are in the way. On the other hand, as convection is 
occurring, there is a change in local solute concentrations. This can interfere with the 
diffusion of small molecules since diffusion rates are dependent on the concentration of 
solutes as the small molecules migrate to lower concentrated areas. As these two 
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occurrences may contribute to delays in the clearance of solutes during the hemodialysis 
process, the interference is inevitable in a hollow fiber dialyzer as diffusion and convection 
will be taking place at the same time and in the same area. Therefore, we have no 
recommendation for the prevention of convection and diffusion interference in a hollow 
fiber dialyzer. 
3.2.3 Reducing Delays within the Water System 
Dialysis patients are continuously subjected to large amounts of water in order to 
filter their blood of toxins. An average hemodialysis patient is exposed to more water in 
one week of treatment than most people are exposed to in a lifetime. Therefore, it is very 
important to have good water quality in order to avoid complications that are associated 
with contamination (Coulliette, 2013). Local water must go through a water treatment 
system in order to remove impurities and excess minerals. Excess of magnesium, 
aluminum, fluoride, and other contaminants can cause problems such as anemia, bone 
disease, and muscle weakness (Mauro, 2015). Therefore, various water treatment system 
designs should be considered in order to reduce the risk of delays associated with stagnant 
water, contamination from bacteria and endotoxin, and biofilm formation.   
When designing a water treatment system, it is important choose the right 
distribution system design and materials. The distribution system is at risk of bacterial 
colonization when there are dead ends, oversized or flat-bottom tanks, sluggish flow, and 
improper disinfection. It is imperative to avoid stagnant water because it is a contributing 
factor to bacterial growth (Oumokhtar, 2013). Dialysis centers have the option between 
direct feed and indirect feed. We recommend the use of the indirect feed system. One thing 
that is advantageous about indirect feed loops is that if the RO system fails there is time to 
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react. In a direct feed, failure results in no water. Direct feed loops also carry the risk of 
retrograde contamination of the dialysis water. In direct feed systems, there could be 
transient pressure fluctuation that results in the water being brought back to the feed side 
of RO having a higher pressure than the end of the dialysis water in the distribution loop 
(Kawanishi, 2011). Indirect feed systems constantly circulate the water even when 
machines are not in use. The direct feed system is not recommended because of the 
possibility of microbial growth/bio-film formation when there is low or no flow (Coulliette, 
2013). Although storage tanks are not ideal with indirect feed loops and should be avoided 
when possible, if a storage tank is to be used, the following designs specifications should 
be considered. The tank should be designed so that water will enter the storage tank from 
above. Therefore, the water will wet the anterior surface and exit through the inferior. Also, 
the storage tank should be opaque as to help prevent the growth of algae (Perez-Garcia, 
2000).   
Additional design considerations for water systems is the placement of ultra-filters. 
Ultra-filters help prevent bacteria colonization by having a filter in the water line leading 
to the storage tank and in the water loop. Unfortunately, it also decreases the flow rate thus 
decreasing the velocity, as well. One should also consider an ultra-filter on each 
hemodialysis machine prior to the point where the dialysate enters the dialyzer. This will 
ensure that the water entering the machine is in fact endotoxin and bacteria free (Andrysiak, 
2002).  
Pipe tubing material and plumbing design considerations are to help prevent 
bacterial contamination, biofilm formation, and stagnant water. Suitable materials are 
made from PVC and stainless steel. PVC schedule 80 is usually the material of choice in 
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the United States because it is relatively cheap. When using PVC, it is very important to 
use an approved PVC cutter method in order to prevent rough edges. If there are rough 
edges, bacteria can adhere to material. Chamfering of edges reduces the number of burrs 
in the pipes and decreases the amount of stress points. This helps with the design because 
it decreases the likelihood of cracking of the pipes (Andrysiak, 2002). Stainless steel is 
more expensive than PVC but is a material to consider because it is resistant to biological 
corrosion (Perez-Garcia, 2000). Furthermore, a study showed that over a period of 14 years, 
purified water, chemical disinfectants, and water flow rates eventually breakdown PVC, 
causing a surface that is susceptible to bacterial growth (Coulliette, 2013). When designing 
the actual piping route, one must consider the angles and connection points. Instead of 
making a 90 degree turn, one should use two 45 degree angles. This will allow for an even 
flow and prevent stagnation. Connection points should also be as short as possible when 
connecting pipes to the hemodialysis machines. This will minimize the stagnant areas. 
Pipes with a smaller diameter should be used to maintain the highest flow velocity possible 
when entering the hemodialysis machine (Andrysiak, 2002). 
Other considerations that should be made to decrease the amount of microbial 
contamination in the treated water is the infusion of chlorine after the activated carbon filter 
and before RO, in addition to submicronic filters, UV radiation, and disinfecting the 
treatment system with ozone. As for concentrates used in the dialysis process, it is 
recommended that they should have low pH and have high solute concentrations because 
they are less likely to become contaminated. Bicarbonate concentrations and concentrates 
in powdered form are not ideal because they become frequently contaminated (Perez-
Garcia, 2000). 
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The prevention of biofilm formation is very important in the water treatment 
system. Biofilm is very difficult to remove once growth is underway. A study has shown 
that neither heat nor chemical disinfectants were able to eliminate biofilm. Therefore, it is 
important that the initial growth is prevented (Cappelli, 2000). In another study, two 
different method, for a water treatment system, method A and method B, were conducted 
to see which method was more efficient at preventing biofilm formation. During a 12 week 
period, method A, a single RO was compared to method B, a double RO with and electric 
DI. During the study, biofilm was observed in the tubing segment between the water piping 
and the dialysis module. That segment was selected because it does not receive disinfection 
and is more susceptible to bacterial growth than other segments. In method A, tube cultures 
showed positive results in 16% of samples at 22-37 degrees Celsius with amounts greater 
than 100 colony forming units per mL (CFU/mL). Method B was only positive in 3% of 
the samples. Endotoxin levels were positive in 76% of method A samples and were 
negative in all of method B samples. Biofilm formation was present in 91.7% of method A 
samples and only present in one of method B samples. In the following images, one can 
see examples of biofilm in tubing segments of method A and method B, taken after the 12 
week period.  
 
Figure 40: 400X Magnification for Method A Showing Formation of Biofilm 
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Figure 41: 400X Magnification for Method B Showing No Formation of Biofilm 
The project team concludes that method B has a significant reduction in biofilm 
formation, bacterial growth, and endotoxin levels. Therefore, it is more beneficial to use a 
water treatment system that has a double RO, electric deionization, and is continuously 
disinfected with UV light and treated with ozone once per week to produce highly purified 
water shown in method B rather than just the standard purified water in method A (Smeets 
et al., 2003). Through research, it is very apparent that system design and prevention of 
contaminants and biofilm formation are important in order to decrease the amount of delays 
in the dialysis treatment process. It is critical to decrease the threat of health complications 
associated with contaminants and biofilm, which make the treatment process more difficult 
and uncomfortable. We recommend an indirect feed system, proper disinfection of the 
system, stainless steel material, and incorporating a double RO with an electric deionizer 
in order to help achieve a safer and comfortable treatment for patients. 
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CHAPTER 4. CONCLUDING REMARKS 
Overall, the dialysis machine has three main components: the dialysate delivery 
system, the extracorporeal blood-delivery circuit and dialyzer. Throughout these 
components there are various delays that through research we were able to develop 
alternate designs to reduce. For the extracorporeal blood-delivery circuit we focused on the 
tubing system, the access point for the patient, and the dialyzer. The dialysate delivery 
system delays were narrowed down to the water system and preventing contamination. 
 The sources of delays in the tubing system that we addressed were the excess 
tubing, large tubing volume and air to blood contact. In a Fresenius 2000K2 dialysis 
machine there is a significant amount of excess tubing so that it develops what are called 
“spaghetti loops.” This increases the travel time of the blood, increasing the amount of time 
it takes for treatment. Also, since there is a risk of air getting into the bloodline, there is a 
greater risk that sensors will go off, resulting in a delay in the process. From our literature 
review and multiple clinical studies, we recommend implementing a new brand of tubing 
called Streamline tubing. 
 The sources of delays associated with the water treatment system are contamination 
of the dialysis water and the formation of biofilm where stagnant water is a major 
contributing factor. The design of the dialysis water treatment system is important in order 
to minimize areas of stagnant water. However, the design alone will not completely prevent 
contamination. Proper monitoring and maintenance of the system is crucial to prevent and 
control any bacterial or endotoxin contamination. Contamination of the water system is 
related to adverse health effects, making the treatment unsafe for patients and increasing 
treatment time.  From our literature research, we recommend using stainless steel tubing, 
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indirect feed loop, a double RO with an electric DI, followed by proper maintenance and 
disinfection of the system. 
 In the Fresenius 2000K2 dialysis machine, a modular system is used for the 
extracorporeal blood circuit. The modular system is bulky, contains dead space, and has 
limited options for incorporating new components such as different sensors. Also, it 
contains a myriad of tubing, which can result in treatment delays, such as a lengthier 
process, when a complication associated with misassembly, leakage or breakage of tubing 
occurs.  Through review of different patents, we recommend the integration of a modified 
cartridge with streamline tubing, color-coded manifolds, and disposables in future dialysis 
machines. 
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APPENDICES 
Appendix A. EPA’s List of Contaminants  
Key: 
  Microorganisms   Inorganic 
Chemicals 
  Disinfection 
Byproducts 
  Organic Chemicals 
  Disinfectants   Radionuclides 
 
EPA’s List of Contaminants with Associated Sources, MCL, and Effects 
Contaminant 
MCL 
Goal 
(mg/L) 
MCL or 
Treatment 
Technique 
(mg/L) 
Potential Health Effects 
from Long-Term 
Exposure Above 
the MCL  
Sources of Contaminant 
in Drinking Water 
Legionella 0 TT3 
Legionnaire's Disease, a 
type of pneumonia 
Found naturally in water; 
multiplies in heating 
systems 
Viruses 
(enteric) 
0 TT3 
Gastrointestinal illness 
(such as diarrhea, 
vomiting, and cramps) 
Human and animal fecal 
waste 
Bromate 0 0.01 
Increased risk of cancer Byproduct of drinking 
water disinfection 
Chlorite 0.8 1 
Anemia; infants and 
young children: nervous 
system effects 
Byproduct of drinking 
water disinfection 
Chloramines 
(asCl2) 
MRDL
G=41 
MRDL=4.0
1 
Eye/nose irritation; 
stomach discomfort, 
anemia 
Water additive used to 
control microbes 
Chlorine 
(as Cl2) 
MRDL
G=41 
MRDL=4.0
1 
Eye/nose irritation; 
stomach discomfort 
Water additive used to 
control microbes 
Chlorine 
dioxide 
(as ClO2) 
MRDL
G=0.81 
MRDL=0.8
1 
Anemia; infants and 
young children: nervous 
system effects 
Water additive used to 
control microbes 
Arsenic 0 
0.010 as of 
01/23/06 
Skin damage or 
problems with 
circulatory systems, and 
may have increased risk 
of getting cancer 
Erosion of natural 
deposits; runoff from 
orchards, runoff from 
glass and electronics 
production wastes 
Chromium 
(total) 
0.1 0.1 
Allergic dermatitis Discharge from steel and 
pulp mills; erosion of 
natural deposits 
Fluoride 4 4 
Bone disease (pain and 
tenderness of the 
Water additive which 
promotes strong teeth; 
erosion of natural 
 89 
bones); Children may 
get mottled teeth 
deposits; discharge from 
fertilizer and aluminum 
factories 
Benzene zero 0.005 
Anemia; decrease in 
blood platelets; 
increased risk of cancer 
Discharge from factories; 
leaching from gas storage 
tanks and landfills 
Chlordane zero 0.002 
Liver or nervous system 
problems; increased risk 
of cancer 
Residue of banned 
termiticide 
Vinyl 
chloride 
zero 0.002 
Increased risk of cancer Leaching from PVC 
pipes; discharge from 
plastic factories 
Radium 226 
and Radium 
228 
(combined) 
none7-
--------- 
zero 
5 pCi/L 
Increased risk of cancer Erosion of natural 
deposits 
Uranium zero 
30 ug/Las 
of 12/08/03 
Increased risk of cancer, 
kidney toxicity 
Erosion of natural 
deposits 
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Appendix B. Areas That Need Monitoring 
Summary of Major Areas That Need Monitoring in a Water Treatment System 
Water Softener 
Total hardness in the product water, should not exceed 1 ppm. 
Preferably checked at the end of the each day. 
Pressure drop: May need back-flushing if pressure drop changes 
more than 10 PSI between pre- and post- softener site. 
Brine tank salt level: adequate amount of salt needed in tank to 
allow for resin bead to regenerate by softener 
Carbon Tanks 
Chlorine and chloramine levels after the last carbon tank, 
preferably each shift. 
Pressure drop change of more than 10 PSI leading to back-flush 
when unit is not operating. 
RO 
Water pressure and flow rates through the unit to ensure 
optimum efficiency and life of membrane. A drop in water flow 
rate may mean that membrane is plugging up. 
Resistivity and rejection ratio. <0.80 membrane must be 
changed. 
DO 
Water pressure before and after the unit: a change of more than 
10 PSI may mean that tanks may be getting plugged up. 
Resistivity and conductivity:  
Filters 
All the filters should be regularly monitored for pressure drop 
across the device. 
Ancillary devices 
temperature-blending valve, backflow prevention device, 
booster pump, and acid feed pump should also be regularly 
monitored and maintained. 
 
 
 
 91 
Appendix C. Contaminants in Water 
Contaminants in Water, Their Effects, and Concentration Limits 
Contaminant Toxic health effect Max concentration (mg/L) 
Aluminum  Encephalopathy, bone disease, anemia < 0.01 
Chloramines  Hemolysis, anemia, 
methemoglobinemia 
< 0.10 
Chlorine  0.5 
Copper  Hemolysis, fever, headache, hepatitis < 0.10 
Fluoride  Bone disease, osteomalacia < 0.20 
Nitrate  Cyanosis, methemoglobinemia, 
hypotension, nausea 
< 2.0 
Sulfate  Nausea, vomiting, acidosis 100 
Zinc  Anemia, nausea, vomiting, fever 0.1 
Calcium  Nausea, vomiting, weakness, 
headache, hypertension, malaise, 
cardiac problems 
< 2 (0.1 mEq/L) 
Magnesium  Nausea, vomiting, weakness, 
headache, hypertension, malaise, 
cardiac problems 
< 4.0 (0.3 mEq/L) 
Potassium  Muscle symptoms, bradyrrhythmia, 
death 
8 (0.2 mEq/L) 
Sodium  Hypertension, pulmonary edema, 
headache, thirst, confusion, seizure, 
coma 
70 (3.0 mEq/L) 
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Appendix D. Chemical Intoxication Outbreaks 
Outbreaks Caused by Chemical Intoxication 1960 - 2007 
Contamination  Description Cause 
Aluminum 
Intoxication and seizures in 7 
patients 
exhausted deionization tanks unable to 
remove aluminum in incoming tap water 
Intoxication neurologic 
symptoms, dementia and 
elevated serum levels in 64 
patients, 3 deaths 
aluminum pump was used to transfer acid 
concentrate to the treatment area 
Elevated serum levels detected 
in 10 patients during routine 
screening 
 replacement pump used to pump acid 
concentrate contained aluminum 
components 
Chloramine 
Hemolytic anemia in 41 patients residual disinfectant was not removed 
completely by the carbon tank when the 
facility increased the capacity of the water 
treatment system 
Copper 
Hemolytic syndrome in 12 
patients, 32 episodes with 4 
fatalities 
six hemodialysis centers had partially 
exhausted deionization system resulting in 
low pH water causing the formation of 
copper ions 
Fluoride 
Intoxication in 8 patients, 1 
death 
accidental spill in hydrofluosilic acid at 
drinking water plant lead to excessive 
fluoride levels entering dialysis unit, 
insufficient treatment prior to dialysis 
Intoxication in 9 patients, 3 
deaths 
exhausted deionization tanks discharged a 
bolus of fluoride 
Formaldehyde 
Intoxication in 5 patients, 1 
death 
disinfectant not properly rinsed from the 
distribution system 
Intoxication in 12 patients new filtration system was installed and not 
properly rinsed 
Hydrogen 
peroxide 
Decreased hemoglobin in 3 
pediatric dialysis patients 
H2O2 used to disinfect the system was not 
adequately rinsed from the system due to a 
flat bottom storage tank that could not be 
rinsed 
Nitrate 
Patient developed 
methemoglobinemia 
home dialysis using well water that 
contained nitrate nitrogen (94 mg/l) 
Sodium azide 
Severe hypotension in 9 patients dialysate contaminated with sodium azide 
used as a preservative from new ultrafilters, 
which were labeled “not for medical use” 
Sulfate(s) 
Nausea, vomiting, chills, some 
with fever in 16 patients, 2 
deaths 
source water used to prepare dialysate 
contained volatile organic compounds (CS2, 
CH3, etc.) and additional failures 
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Appendix E. Microbial Contamination Outbreaks 
Outbreaks Caused by Microbial Contamination 1969 - 2008 
 
Contamination 
Description 
Cause 
Bacterial 
Gram-negative bacteria 
bloodstream infections in 8 
patients (Burkholderia cepecia 
complex, Ralstonia sp., 
Pseudomonas aeruginosa, or 
Stenotrophomonas maltophilia) 
Burkholderia cepacia complex found in 
reverse osmosis water, gram-negative 
organisms detected in a patient dialyzer and 
solution distribution system 
Bacteremia episodes (~30) with 
the main gram-negative 
organisms being P. aeruginosa, 
Proteus, and Flavobacterium 
bacteria was found in tap water and dialyzer 
resins, while no chlorine residual was detected 
after deionizer columns 
Pseudomonas cepacia recovered 
from 10 patients (13 cases of 
peritonitis) 
insufficient disinfection of contaminated tap 
water that was used for cleaning dialysis 
machines 
Nontuberculous mycobacterial 
(NTM) infection 
(Mycobacterium chelonae 
subspecies abcessus), 27 cases 
detected in water samples 
Pyrogenic reactions in 14 
patients, 2 with bacteremia and 1 
death 
reverse osmosis water storage tank 
contaminated with bacteria 
*Intradialytic sepsis in 9 patients gram-negative organisms detected in 
predialysis saline rinse, the source was either 
the dialysis fluid or water used for rinsing the 
dialyzers between uses 
*Bacteremia in 6 patients likely source(s) of the gram-negative bacteria 
were the dialysis fluid or water used for 
rinsing dialyzers prior to reuse, as well as the 
improper preparation of the new disinfectant 
*Bloodstream infections of 
Klebsiella pneumonia in 6 
patients 
inadequate disinfection of reprocessed 
dialyzers, as technicians’ gloves were cross 
contaminating from infected patient 
 
 
 
 
Endotoxin 
Pyrogenic reaction in 49 patients untreated tap water used to prepare the 
dialysate contained high levels of endotoxin 
Pyrogenic reaction in 45 patients inadequate disinfection of the fluid distribution 
system 
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*Pyrogenic reactions in 13 
patients 
bacteria was detected in tap water and water 
used to prepare the bicarbonate dialysate, 
endotoxin was detected in the faucet of the 
reprocessing room and the water-spraying 
device used for rinsing 
Pyrogenic reactions in 23 
patients (49 episodes) 
increased endotoxin levels found in the tap 
water used to prepare the dialysate 
*Pyrogenic reactions in 3 
patients 
change in reprocessing methods potentially 
altered the permeability characteristics 
allowing endotoxins to pass through 
membrane 
*Pyrogenic reactions in 16 
patients (18 episodes) 
endotoxin is the believed cause during reuse of 
dialyzers, water used to rinse dialyzers and 
dilute the disinfect was contaminated with 
high concentrations of endotoxins (>6 ng/ml) 
and bacteria (>104 CFU/ml) 
Combined: 
Bacterial & 
Endotoxin 
Pyrogenic reactions and 
bacteremia in 5 patients (2 with 
Klebsiella pneumonia, 1 with K. 
pneumonia and P. aeruginosa) 
distribution systems and machines were 
inadequately disinfected with sodium 
hypochlorite when a pump failed 2 weeks 
prior to the outbreak 
Pyrogenic reactions (9 episodes) 
and gram-negative bacteremia (5 
episodes) in 11 patients 
water distribution system was not routinely 
disinfected, machine was not disinfected 
according to manufacturer's instructions, poor 
bacterial assay resolution 
*Pyrogenic reactions (~20) due 
to bacteria and/or endotoxins 
reverse osmosis water was believed to be the 
source of contamination 
*Pyrogenic reactions in 9 and 
gram-negative bacteremias in 5 
patients 
inadequate mixing of Renalin disinfectant 
Nontuberculous 
mycobacteria 
*A total of 27 cases with various 
infections: bacteremia in 14, 
soft-tissue infections in 3, and 1 
with an access-graft infection, 
while 9 others had widely 
disseminated disease. 
Mycobacterium chelonae ssp. 
abscessus was identified in 26 
isolates and the remaining isolate 
was a M. chelonae-like organism 
the water treatment system showed widespread 
contamination and the processed dialyzers 
were contaminated with viable mycobacterium 
*Systemic M. chelonae 
abscessus infections in 5 
patients, 1 patient died during 
antimicrobial therapy 
a hose with a spray device was contaminated 
with M. abscessus and the Renalin disinfectant 
concentration was not high enough 
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Appendix F. Streamline Tubing Clinical Studies 
Four Clinical Studies Evaluating Streamline Tubing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study Objective 
 
Comprehensive 
Clinical & 
Operational 
Analysis 
Decreasing 
Dialyzer size 
& heparin 
usage 
Lowering QD Maximizing 
Kt/V 
Study Sample 
Size 
117 67 117 202 
Improvement in 
Blood Flow Rate 
(%) 
18% 5% 4% 19% 
Change in 
Arterial Pressure 
(%)  
N/A 16% reduction 12% reduction 4% increase 
(minimal) 
% of patients 
meeting target 
kt/V with 
Streamline 
98.3% 76% 100% 73% 
(target=2) 
Improvement in 
% of patients 
meeting target 
Kt/V with 
Streamline 
+27% +10% +4% +34% 
Cost Savings ($ 
per treatment 
where available) 
 Heparin use 
reduced by 28% 
($0.07) 
 Biohazard waste 
reduction ($0.19) 
 Dialysate usage 
reduced ($1.39) 
 Staff overtime 
reduced ($1.32) 
 Heparin use 
reduced by 
57% ($0.96) 
 Patients on 
large 
dialyzers 
reduced 
69% ($2.52) 
 Dialysate usage 
decreased 7% 
 Fresh water 
usage reduced 
27,000 
liters/month 
 Focused on 
improving 
Kt/V; cost 
savings not 
reported 
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Appendix G. Modular Components 
Modular Components of the Fresenius 2008K2 Dialysis Machine 
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Appendix H. Cartridge Iterations 
Design Iterations for Modified Cartridge 
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